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ABSTRACT 
 
Epidemiological studies have linked high consumption of tomatoes and cruciferous 
vegetables to decreased risk of prostate cancer.  Several bioactive components isolated from 
cruciferous vegetables and tomatoes exhibit anti-cancer properties.  Previous studies have 
evaluated the cancer preventive potential of these individual bioactives, but few have examined 
them within the context of a whole food.   
In a pilot study to evaluate bioactivity of different tomato and broccoli powders, male 
Copenhagen rats were fed diets containing 10% standard tomato powder, tomato enriched with 
lycopene or total carotenoids, standard broccoli floret, broccoli sprouts, or broccoli enriched with 
indole glucosinolates or selenium for 7 days.  All broccoli diets increased activity of colon 
quinone reductase (NQO1).  Indole glucosinolate-enriched broccoli and selenium-enriched 
broccoli increased hepatic NQO1 and cytochrome P450 1A activity (P < 0.05).  Different tomato 
diets resulted in altered hepatic accumulation of lycopene, phytofluene, and phytoene.  These 
results demonstrate that the bioactive content of vegetables affects both tissue content of 
bioactives and activity of detoxification enzymes.  Enhancing bioactive content of tomatoes and 
broccoli may enhance efficacy in the prevention of prostate cancer. 
Based on the results of this pilot study, our next objective was to determine if standard 
broccoli or the indole glucosinolate-enriched (IG) broccoli, would impact prostate carcinogenesis 
in the aggressive TRAMP model.  Male mice were randomized into 3 diet groups at 5-7 weeks of 
age: AIN-93G control, 10% control broccoli powder, or 10% IG broccoli powder.  Diets were 
fed throughout the study until termination at 20 weeks of age, with no differences in body weight 
or food intake observed between groups.  There were no differences between groups in 
genitourinary tract weight, a surrogate marker of tumor volume, and no differences were found 
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in cancer grade upon histopathologic evaluation indicating that broccoli feeding did not impact 
cancer aggressiveness.  The horticultural manipulation of broccoli to alter phytochemical 
concentration is a feasible approach to optimizing the potential for cancer prevention, yet optimal 
patterns of phytochemicals remain to be characterized. 
To assess potential epigenetic effects of lycopene, we examined the effects of lycopene 
and its metabolite, apo-10’-lycopenal, on methylation of the GSTP1 promoter in LNCaP cells.   
GSTP1 is hypermethylated in >90% of prostate cancers, which results in complete silencing of 
the gene.  Neither lycopene nor apo-10’-lycopenal altered mRNA expression or DNA 
methylation of GSTP1 indicating that lycopene is not an effective demethylating agent for this 
gene in this particular prostate cancer cell line.  It remains to be seen if lycopene has epigenetic 
effects on other genes or in other cell lines. 
Overall we have demonstrated that the bioactive content of tomatoes and broccoli can be 
altered through agronomic means, but optimal profiles for cancer prevention remain to be 
determined.  Much remains to be learned about how tomatoes and broccoli alter cancer 
progression at different stages and the mechanisms through which they exert their effects.
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CHAPTER 1 
 
LITERATURE REVIEW 
 
Introduction 
Cancer is a class of over 100 diseases characterized by uncontrolled cell growth.  An 
individual’s chances of developing cancer are governed by multiple risk factors including family 
history, age, race, diet, exercise, and environmental exposures.  Many of these risk factors can be 
modified through individual behavior.  In 1980, Doll and Peto estimated that approximately 35% 
of human cancer deaths could be prevented through dietary modifications (1).  This work 
suggested that the food choices a person makes every day can have profound impacts on his or 
her risk of developing cancer over a lifetime. 
Prostate cancer is the most commonly diagnosed cancer and second leading cause of 
male cancer deaths in United States with approximately 186,000 new cases diagnosed each year 
(2).  Early diagnosis and intervention is important as metastatic disease accounts for the majority 
of deaths.  Dietary interventions may play an important role in delaying prostate cancer growth, 
especially because it is a slow growing cancer that takes decades to develop. 
 
Development of Prostate Cancer 
Prostate cancer is mainly a disease of aging with 63% of all prostate cancer cases 
diagnosed in men over the age of 65 (3).  Between the ages of 40 and 65, the risk of developing 
prostate cancer increases 1000 times (4).  However, the premalignant lesions that may lead to 
prostate cancer appear in men as early as their 20s suggesting that diet has the potential to 
influence risk from a young age (5).   
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The pathologic progression of prostate cancer can be classified as follows: normal 
prostate epithelium, proliferative inflammatory atrophy (PIA), prostatic intraepithelial neoplasia 
(PIN), localized prostate cancer, metastatic prostate cancer, androgen-independent prostate 
cancer (Figure 1.1).   
 
Figure 1.1.  Development of human prostate cancer. 
 
PIA is a candidate precursor lesion to prostate cancer characterized by hyperproliferative 
glandular epithelium with the morphological appearance of atrophy and accompanied by 
inflammation (6).  At this time, its relationship to prostate cancer development is speculative.  
PIN is a precursor lesion to prostate cancer and is the earliest accepted stage in prostate 
carcinogenesis.  It is a proliferation of irregular, atypical epithelial cells with progressive 
disruption of the basal cell layer in the absence of stromal invasion.  Duct and gland architecture 
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remain intact.  PIN is generally divided into low-grade and high-grade PIN.  High-grade PIN is a 
standard clinical diagnosis that must be included in pathological evaluations of prostate biopsies.  
Low grade PIN is often not reported in pathologic evaluations because its utility is limited by 
high levels of inter-observer variability (7).  Approximately 30-40% of men with high grade PIN 
will have developed prostate cancer upon repeat biopsy (7).  
 Over 90% of prostate cancers in the United States are discovered in the localized 
(confined to the prostate) and regional (extending into nearby surrounding tissues) stages where 
the 5-year survival rate approaches 100% (3).  When distant site metastases are found, the 5-year 
survival rate drops to approximately 30% (2).  Autopsy studies indicate that most men over the 
age of 85 have histological prostate cancer, but these small, localized cancers remain latent and 
unrecognized for many years (4).  Overall 5-year survival rates for men with prostate cancer are 
98%, suggesting that men are much more likely to die with prostate cancer than to die from 
prostate cancer. 
 Current treatment options for prostate cancer include expectant management, radiation 
therapy, and surgery.  Expectant management (a.k.a. watchful waiting) is appropriate for patients 
with a life expectancy of less than 10 years and for men 65 years of age or older who have a low-
volume, low-grade prostate cancer (8).  Patients are followed closely with serum PSA testing and 
digital rectal exams every six months.  Biopsies are performed at frequent intervals.  Radiation 
therapy is an option for patients with localized prostate cancer with various degrees of severity.  
Radiation beams are focused to the prostate, or radioactive iodine-125 or palladium-103 seeds 
are implanted directly in the prostate.  It is less invasive than surgery and tends to have fewer 
complications.  Radical prostatectomy is a surgical procedure that involves removal of the entire 
prostate, seminal vesicles, and sufficient surrounding tissue.  It can be performed through open 
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incisions or laproscopically.  If the cancer becomes hormone refractory or metastatic, 
chemotherapy may be used.  Dietary intervention would likely be most appropriate for men 
undergoing expectant management because of the low-grade of the cancer and it would not 
interfere with any medical therapies. 
  
Fruit and Vegetable Consumption in the United States 
It is generally recognized that fruits and vegetables are important components of a 
healthy diet.  The 2005 Dietary Guidelines for Americans recommends that people consume 2 
servings of fruit and 3 servings of vegetables per day and that they choose a variety of different 
fruits and vegetables (9).  In spite of this, only 14% of U.S. adults achieve the recommended 
levels of both fruits and vegetables (10). Tomatoes are the second most commonly consumed 
vegetable in the American diet second only to potatoes (11).  In 2007, the average American 
consumed 19.2 pounds of fresh tomatoes and 68.8 pounds of processed tomato products.  
Broccoli is the tenth most consumed vegetable with the average American eating 5.6 pounds of 
fresh broccoli and 2.7 pounds of frozen broccoli products (total 8.3 pounds) annually.   Whereas 
broccoli intake is substantially less than that of tomatoes, consumption has been gradually 
increasing since 1970 when the average American only ate 1.5 pounds of broccoli each year 
(12). 
 
Epidemiological Associations Between Tomatoes, Broccoli, and Prostate Cancer 
In recent decades there has been a surge of interest in the role of bioactive 
phytochemicals in reducing chronic disease risk.  Consumption of fruits and vegetables is 
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important for general health, but it has also been linked to reduced risk of chronic diseases such 
as cancer (13).  However, the literature is not without controversy.   
Interest in the role of tomatoes in prostate cancer blossomed after 1995 when 
Giovannucci et al. published a report from the Health Professional’s Follow-up Study, a 
prospective cohort study of 50,000 American men (14).  Their results demonstrated a 
significantly reduced risk of prostate cancer in men with high intakes of tomato sauce (P=0.001), 
tomatoes (P=0.03), and pizza (P=0.05).  However, a decade later, two different reviews of the 
epidemiological literature came to two very different conclusions on the role of tomato products 
in prostate cancer prevention.   
In 2007, the FDA published a report of their evidence-based review for qualified health 
claims regarding tomatoes or lycopene for prostate cancer.  After reviewing 81 observational 
studies examining the relationship between lycopene and various cancers and 64 studies 
examining the relationship between tomato products and various cancers, the FDA found “no 
credible evidence to support an association between lycopene intake and reduced risk of prostate 
cancer [and] very limited evidence to support an association between tomato consumption and 
reduced risk of prostate cancer” (15).  Just a few months later, an international expert panel 
convened by the World Cancer Research Fund concluded in their report that “foods containing 
lycopene probably protect against prostate cancer” (13).  Additionally they stated: “there is a 
substantial amount of consistent evidence, in particular on tomato products, both from cohort and 
case-control studies.”  One of the key reasons for this discrepancy in interpretation of the same 
body of literature may be the lack of definitive randomized human trials.  However, it also 
highlights the need for further research in this area to better address the role of tomato products 
in preventing prostate carcinogenesis.  
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In contrast to tomatoes, literature on the relationship between broccoli consumption and 
prostate cancer risk is quite sparse.  The majority of studies look at the relationship between the 
family of cruciferous vegetables and cancer risk.  A 2002 review by Kristal and Lampe evaluated 
the 12 published studies reporting on the associations between Brassica consumption and 
prostate cancer risk and concluded that “the epidemiological literature provides moderate support 
for the hypothesis that high intakes of Brassica vegetables reduce prostate cancer risk.” (16).  
More recently, a 2007 report from the Prostate, Lung, Colorectal and Ovarian Cancer Screening 
Trial found that men consuming >1 serving of broccoli per week had a 45% reduction in risk of 
developing aggressive prostate cancer compared to men consuming <1 serving of broccoli per 
month (17).  While the literature is suggestive of a possible protective effect of cruciferous 
vegetable consumption, much more research is needed to come to a definitive consensus. 
 
Intervention Studies with Tomatoes or Broccoli 
 Consumption of tomato juice has been demonstrated to reduce oxidative DNA damage in 
leukocytes of healthy individuals (18).  These results suggest that carotenoid-containing plant 
products may decrease DNA damage in humans and thus exert cancer-protective effects.  To 
determine how tomato products might act in the prostate, it is first necessary to establish whether 
compounds of interest such as carotenoids accumulate in the prostate.  Clinton et al. 
demonstrated that the lycopene and -carotene are the predominant carotenoids found in the 
prostate, and -carotene, lutein, zeaxanthin, -cryptoxanthin, and -cryptoxanthin are all 
consistently detectable in prostate tissue (19).  Though there was large intra-individual variation, 
an array of carotenoids could be detected in the prostate. 
 7 
 Two small clinical trials have evaluated the effects of tomato-based products in men with 
prostate cancer.  In a phase II clinical trial, Kucuk et al. randomized 26 men with clinically 
localized prostate cancer to receive either Lyc-O-Mato capsules or no supplement for 3 weeks 
prior to radical prostatectomy (20).  The Lyc-O-Mato capsules contained 15 mg of lycopene, 2.5 
mg of phytoene/phytofluene, and small amounts of other carotenoids found in tomatoes.  In the 
intervention group, 73% of subjects had no involvement of surgical margins and/or extraprostatic 
tissues with cancer compared to 18% in the control group (P = 0.02).  These results suggest that 
lycopene may reduce the microscopic extension of prostate cancer and may be useful as an 
adjunct to standard prostate cancer treatments. 
 Chen et al. determined the effects of tomato sauce-based pasta dishes on oxidative DNA 
damage and PSA levels in 32 patients with localized prostate cancer (21).  Subjects consumed 
one tomato sauce-based pasta dish containing approximately 30 mg lycopene per day for 3 
weeks.  After the intervention period, subjects had significantly increased serum and prostate 
lycopene levels, decreased leukocyte oxidative DNA damage, and decreased serum PSA levels.  
While these results appear promising, the study suffered from lack of a control group and a small 
sample size. 
 No studies thus far have evaluated the effects of broccoli or broccoli bioactives in 
prostate cancer patients.  Trials have been performed to define the pharmacokinetics of certain 
broccoli bioactives such as sulforaphane and indole-3-carbinol (22, 23), but thus far no research 
has evaluated accumulation of these compounds in the prostate.  One clinical trial has examined 
the effects of a broccoli-rich diet on global gene expression in the prostate of men with high 
grade PIN (24).  Twenty-two men with a previous diagnosis of HGPIN (a precusor lesion to 
prostate cancer) were randomized to consume wither 400 g broccoli or 400 g peas per week for 
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12 months, and prostate biopsies were taken at 6 and 12 months.  Men on the broccoli diet had 
alterations in the TGF1, EGF, and insulin signaling pathways after 12 months as measured via 
pathway analysis.  Further research is needed to clarify how broccoli consumption alters these 
pathways and how that in turn affects prostate carcinogenesis. 
 
Animal Studies with Tomatoes or Broccoli 
 A limited number of animal studies have examined the effects of whole tomatoes or 
broccoli on prostate carcinogenesis.   Our lab has previously shown that whole tomato powder is 
more effective than lycopene alone in two different animal models of prostate cancer.  In a rat 
model of prostate cancer induced by testosterone and N-nitroso-N-methylurea, rats fed a 10% 
tomato powder diet lived significantly longer than rats fed control diet or lycopene beadlets (25).  
Similarly, in the Dunning transplantable tumor rat model, a 10% tomato powder diet 
significantly reduced tumor weights whereas both low and high levels of lycopene alone did not 
(26).  In contrast, work by Konijeti et al. found that TRAMP mice fed lycopene beadlets had 
decreased incidence of prostate cancer whereas mice fed tomato paste did not (27).  However 
work by a different group in the same model, found that feeding 10% tomato powder 
significantly delayed progression from PIN to adenocarcinoma (28).  Adding a new insight into 
the tomato and prostate cancer story, Mossine et al. demonstrated that ketosamines, a class of 
carbohydrate derivatives present in dehydrated tomato products, may impact tumorigenesis in the 
highly metastatic rat prostate adenocarcinoma MAT-LyLu (29).  The combination of FruHis and 
lycopene was the most effective in reducing in vivo tumor formation suggesting that ketosamines 
may be non-carotenoid components of tomatoes that contribute to the inhibition of 
carcinogenesis. 
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 Thus far, only one study has examined the effects of whole broccoli on prostate cancer in 
an animal model.  Canene-Adams et al. demonstrated that a diet containing 10% broccoli powder 
significantly reduced tumor weights compared to the control group (26).  Numerous other studies 
have examined the effects of individual compounds such as sulforaphane and indole-3-carbinol. 
 
Bioactives in Tomatoes and Broccoli 
The health benefits of functional foods are often associated with their bioactive 
components that are believed to deliver a health benefit beyond basic nutrition.  Tomatoes 
contain carotenoids, which are a class of over 600 lipophilic compounds that impart color to 
fruits and vegetables.  Lycopene is the most abundant carotenoid in tomatoes followed by its 
colorless precursors, phytoene and phytofluene.  Whereas the bioactive properties of lycopene 
have been extensively studied, little is known about the biological roles of phytoene and 
phytofluene.  Broccoli contains glucosinolates which are a class of phytochemicals abundant in 
Brassica vegetables.  Intact glucosinolates are relatively biologically inactive, but when the plant 
tissue is disrupted glucosinolates undergo enzymatic hydrolysis by  myrosinase.  Glucosinolates 
can go on to form many different breakdown products, depending on the reaction conditions, 
with diverse biological activities (Figure 1.2).  Some well-known glucosinolate hydrolysis 
products include sulforaphane and indole-3-carbinol. 
Individual bioactives have been shown to have wide-ranging effects on biological 
processes.  For instance, lycopene in tomatoes may help maintain prostate health, and 
sulforaphane (SF), a hydrolysis product of glucoraphanin from broccoli may enhance 
detoxification of carcinogens.  The anti-carcinogenic properties of tomatoes and broccoli are 
often attributed to individual bioactives such as lycopene from tomatoes and sulforaphane and  
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Figure 1.2. Glucosinolate metabolism. 
 
indole-3-carbinol from broccoli.  Each of these bioactives has been reported to act through a 
variety of mechanisms including inhibition of cell cycle progression and induction apoptosis in 
various cancer cell lines (30-32).  Additionally, lycopene is a potent antioxidant and some of its 
other purported mechanisms of action include increased gap-junctional communication, 
inhibition of androgen signaling, and inhibition of IGF-1 signal transduction (33).  Sulforaphane 
increases the transcription of genes containing an antioxidant response element (ARE) including 
several phase II detoxification enzymes.  It is also may have anti-inflammatory activities and 
may act as a histone deacetylase inhibitor (34).   Indole-3-carbinol induces both phase I and 
phase II enzymes and may alter estrogen metabolism and transcription of estrogen responsive 
genes (35). 
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Much research has examined the putative health benefits of individual, isolated bioactive 
compounds.  However, in many in vitro studies these bioactive compounds are provided at levels 
tens to hundreds of times greater than can be physiologically achieved through incorporation of 
whole foods into the diet.  Furthermore, these compounds are typically tested as the aglycone 
form in cell culture, although they are present as glycosides in plant foods and conjugates in the 
body following absorption.  Therefore it is also important to consider the impact of chemical 
form on bioavailability and bioactivity during dietary interventions in vivo.  Once the efficacy of 
functional food components is verified, enhancing the concentrations of health-promoting 
compounds in foods may be beneficial in preventing and treating chronic diseases such as 
cancer. 
Humans also normally consume tomatoes and broccoli as whole foods whether fresh, 
frozen, or processed.  The whole vegetable contains many other nutrients and phytochemicals 
which may act additively or synergistically to produce a greater effect than can be accounted for 
by one bioactive alone. Indeed tomatoes contain high levels of other carotenoids, and they are 
good sources of potassium, folate, and vitamins A, C and E.  Broccoli contains many different 
glucosinolates, and it is also a good source of dietary fiber, folate, and vitamins A, C and K.  
Previous work from our lab has shown that whole tomato powder is more effective than 
lycopene alone in reducing prostate cancer growth in rat models (25, 26). 
 
Bioactive Enrichment/Biofortification of Tomatoes and Broccoli 
Biofortification has traditionally been considered the enhancement of micronutrient 
levels in staple crops through traditional breeding practices and/or genetic modification (36).  
The main goal has been to alleviate micronutrient deficiencies in the world population especially 
 12 
for vitamin A, iron, and zinc.  One of the most well known examples of a biofortified crop is 
golden rice, which has higher levels of -carotene, a vitamin A precursor (37). 
 In recent years, researchers have begun to investigate whether enhancement of bioactive 
compounds in food crops can lead to reductions in chronic diseases such as cancer.  For reducing 
the formation of aberrant crypt foci in a chemically-induced rat model of colon cancer, selenium-
enriched broccoli was shown to be more effective than high doses of selenite alone or a 
combination of selenite and broccoli sprout powder low in selenium (38).  “Super broccoli” has 
been bred to have high glucoraphanin levels (10.6 compared to 4.4 mol/g dry weight in some 
store-bought broccoli varieties), and it enhances transforming growth factor 1 signaling which 
is important for controlling cell proliferation (24).   Another study found that a purple 
anthocyanin-enriched tomato was more effective than regular red tomato in increasing the 
survival time of Trp53-/- mice which predominantly develop lymphomas (39).  These studies 
provide encouraging evidence that enrichment of tomatoes and/or broccoli with bioactives may 
be beneficial in reducing cancer growth. 
 
Mechanisms of Action: Epigenetic Modifications 
Epigenetic changes are defined as heritable changes in gene expression that take place 
without a change in DNA sequence.  The two major types of epigenetic change are modifications 
to DNA, in the form of DNA methylation, and modifications to chromatin packaging, 
specifically histone modification.  DNA methylation is critical for regulation of gene activity and 
structure of the cell nucleus.  Aberrant DNA methylation patterns are commonly seen in human 
cancers and often consist of global hypomethylation of DNA accompanied by hypermethylation 
of specific genes including some tumor-suppressor genes (40).  Currently, specific genes such as 
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glutathione S-transferase P1 (GSTP1) are being investigated to determine if their methylation 
status can serve as an early and specific biomarker of prostate cancer (41-43). 
Gluathione S-transferases (GSTs) are a large family of detoxification enzymes which 
catalyze conjugation reactions with reduced glutathione.  They play an important role in 
protecting DNA from reactive electrophilic compounds and oxidants. GSTP1 is hypermethylated 
in >90% of prostate cancer cases and 70% of prostatic intraepithelial neoplasia (PIN) lesions 
making it one of the earliest and most commonly found genome alterations in prostate cancer 
(43).  Mice that are null for GSTP1 develop skin tumors at significantly increased rates 
compared to wild type mice when exposed to the carcinogen 7,12 dimethylbenz[a]anthracene 
(44).  GSTP1 is completely silenced in LNCaP human prostate cancer cells due to 
hypermethylation (45).  When these cells are exposed to PhIP, high levels of PhIP-DNA adducts 
are formed, but when the cells are modified to express GSTP1 they are resistant to the formation 
of PhIP-DNA adducts (46).  These data demonstrate that GSTP1 may play a key role in the 
prevention of cancer formation. 
Recent data suggest that certain dietary compounds may prevent cancer through 
epigenetic modifications in the cell (47, 48).  In particular, lycopene has been shown to partially 
demethylate the GSTP1 promoter and restore GSTP1 expression in breast cancer cell lines (49).  
While this effect has not been examined in prostate cancer cells, these data suggest that lycopene 
may be a candidate for preventing or slowing prostate cancer growth through alterations in DNA 
methylation patterns. 
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Methylation Patterns in Prostate Cancer Cell Lines 
Aberrant DNA methylation patterns have commonly been associated with human cancers 
and may be one of the earliest genome alterations in prostate cancer.  In studying prostate cancer, 
cell lines are often employed, but each line has it’s own unique characteristics since each was 
derived from an individual cancer.  Yengnasubramanian et al. assessed the extent of 
hypermethylation at 16 CpG islands in seven prostate cancer cell lines, normal prostate epithelial 
cells, normal prostate stromal cells, primary prostate cancers, metastatic prostate cancers, and 
noncancerous prostate tissue (41).  Each cell line had its own unique methylation pattern with 
regard to the 16 CpG islands examined (Figure 1.3).  However, the CpG islands at GSTP1, APC, 
RASSF1a, PTGS2, and MDR1 were hypermethylated in >85% of prostate cancers and cancer 
cell lines, but not in normal prostate cells or tissues indicating that they might be particularly 
useful for distinguishing between cancerous and benign prostate tissue. 
 GSTP1 is known to be completely hypermethylated in LNCaP cells (45) and completely 
unmethylated in normal prostate epithelial cells (PrEC) and normal prostate stromal cells (4ST) 
(41). 
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Figure 1.3.  Normalized index of methylation (NIM) for prostate cancer cell lines and normal 
prostate and epithelial and stromal cells.  The NIM was color scaled between white (representing 
no methylation detected) and red (indicating that >99% of bisulfite-converted input copies were 
methylated). *, indicates NIM values <0.20 but greater than the calculated threshold for each 
CpG island (41). 
 
The TRAMP Model 
The Transgenic Adenocarcimoma of the Mouse Prostate (TRAMP) model was 
established in 1995 by Dr. Norman Greenberg (50).  The model was generated in C57BL/6 mice 
by microinjection of a construct containing the simian virus 40 T antigen (SV40 Tag) under 
transcriptional control of a rat probasin promoter (PB).  The PB gene encodes an androgen-
regulated protein specific to the dorsolateral epithelium.  This restricts expression of the 
transgene specifically to the prostate and results in activation of the transgene during puberty 
when androgen levels rise.  The SV40 Tag is an oncoprotein which binds and abrogates function 
of retinoblastoma (Rb) and p53 tumor-suppressor proteins 
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 TRAMP mice develop progressive prostate cancer similar to clinical prostate cancer 
(Figure 1.4).  The cancer is invasive and capable of metastatic spread to the lungs and lymph 
nodes.  Mice castrated at 12 weeks of age develop androgen-independent cancer which may 
serve as a model for hormone-refractory cancer (51).  The main outcomes measured in this 
model include pathological tumor grade, genitourinary tract weight (a surrogate measure of 
tumor volume), and metastasis incidence (52). 
 
 
Figure 1.4.  Prostate cancer progression in the TRAMP model (52).   
 
Aims of Dissertation 
Bioactive-enrichment of vegetables for the reduction of cancer growth is a relatively new 
field that has so far yielded promising results.  Here we investigate whether bioactive-enriched 
tomatoes and broccoli can be produced through agronomic means, examine their effects on 
prostate carcinogenesis, and investigate possible mechanisms of action.  The overall hypothesis 
of this work is that enhancing the bioactive content of tomatoes and broccoli will reduce prostate 
carcinogenesis.  The specific aims of this work were to: 
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1. Obtain tomato and broccoli powders with enhanced levels on specific bioactives and 
screen them for bioactivity. 
2. Test the efficacy of standard broccoli vs. methyl jasmonate-treated broccoli, which is 
high in indole glucosinolates, in reducing prostate carcinogenesis in the TRAMP model 
3. Examine whether lycopene or apo-10’-lycopenal can restore expression of silenced tumor 
suppressor genes in prostate cancer cells through epigenetic modifications. 
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CHAPTER 2 
 
FEEDING TOMATO AND BROCCOLI POWDERS ENRICHED WITH BIOACTIVES 
IMPROVES BIOACTIVITY MARKERS IN RATS
1,2
 
 
ABSTRACT 
Many studies have evaluated the cancer preventive potential of individual bioactives from 
tomatoes and broccoli, but few have examined them within the context of a whole food.  Male 
Copenhagen rats were fed diets containing 10% standard tomato powder, tomato enriched with 
lycopene or total carotenoids, standard broccoli floret, broccoli sprouts, or broccoli enriched with 
indole glucosinolates or selenium for 7 days.  All broccoli diets increased activity of colon 
quinone reductase (NQO1).  Indole glucosinolate-enriched broccoli and selenium-enriched 
broccoli increased hepatic NQO1 and cytochrome P450 1A activity (P < 0.05).  Standard 
broccoli and lycopene-enriched tomato diets down-regulated prostatic glutathione-S-transferase 
P1 mRNA expression.  Different tomato diets resulted in altered hepatic accumulation of 
lycopene, phytofluene, and phytoene.  These results demonstrate that the bioactive content of 
vegetables affects both tissue content of bioactives and activity of detoxification enzymes.  
Enhancing bioactive content of tomatoes and broccoli may enhance efficacy in the prevention of 
prostate cancer. 
 
INTRODUCTION 
The health benefits of functional foods are often associated with their bioactive 
components that are believed to deliver a health benefit beyond basic nutrition.  For instance, 
lycopene in tomatoes may help maintain prostate health, and sulforaphane (SF), a hydrolysis 
                                                 
1
 This chapter was the result of a collaboration between the following authors: Ann G. Liu, Sonja 
E. Volker, Elizabeth H. Jeffery, and John W. Erdman, Jr. 
2
 Reproduced with permission from. J. Agric. Food Chem. Copyright 2009. 
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product of glucoraphanin from broccoli may enhance detoxification of carcinogens.  Much 
research has examined the putative health benefits of individual, isolated bioactive compounds.  
However, in many in vitro studies these bioactive compounds are provided at levels tens to 
hundreds of times greater than can be physiologically achieved through incorporation of whole 
foods into the diet.  Furthermore, these compounds are typically tested as the aglycone form in 
cell culture, although they are present as glycosides in plant foods and conjugates in the body 
following absorption.  Therefore it is also important to consider the impact of chemical form on 
bioavailability and bioactivity during dietary interventions in vivo.  Once the efficacy of 
functional food components is verified, enhancing the concentrations of health-promoting 
compounds in foods may be beneficial in preventing and treating chronic diseases such as 
cancer. 
In 1981, Doll and Peto estimated that approximately 35% of human cancer deaths could 
be prevented through dietary modifications (1).  This led to an extensive study of fruit and 
vegetable intake as a modifiable risk factor.  Epidemiological studies have linked higher 
consumption of tomatoes and cruciferous vegetables with a decreased risk of prostate cancer (2, 
3).  The efficacy of these vegetables is often associated with the anti-cancer actions of individual 
bioactives such as lycopene, SF, indole-3-carbinol (I3C, hydrolysis product of the indole 
glucosinolate glucobrassicin), and selenium. While these bioactives have been shown to have 
individual anti-cancer effects, they may also act additively or synergistically with the many other 
vitamins, minerals, and bioactive phytochemicals in tomatoes and broccoli to reduce tumor 
growth.  
A few previous studies have examined the effects of increasing the bioactive content of 
tomatoes and broccoli on the reduction of cancer growth.  For reducing the formation of aberrant 
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crypt foci in a chemically-induced rat model of colon cancer, selenium-enriched broccoli was 
shown to be more effective than high doses of selenite alone or a combination of selenite and 
broccoli sprout powder low in selenium (4).  “Super broccoli” has been specifically bred to have 
high glucoraphanin levels (10.6 compared to 4.4 mol/g dry weight in store-bought broccoli), 
and it enhances transforming growth factor 1 signalling which is important for controlling cell 
proliferation (5).   Another study found that an anthocyanin-enriched tomato was more effective 
than regular red tomato in increasing the survival time of Trp53-/- mice which predominantly 
develop lymphomas (6).  These studies provide encouraging evidence that enrichment of 
tomatoes and/or broccoli with bioactives may be beneficial in reducing cancer growth.   
Dietary interventions may play an important role in delaying prostate cancer growth 
especially since it is a slow-growing cancer that takes decades to develop. Optimizing the 
content of bioactive components within tomatoes and broccoli may provide an important boost to 
the effectiveness of these vegetables, especially considering that less than half of the US 
population meets recommended intake levels for fruits and vegetables (7). 
The purpose of this study was to evaluate the effects of pre-harvest enrichment of tomato 
and broccoli with different bioactives on tissue accumulation and bioactivity markers in male 
Copenhagen rats in a 7-day screening trial for a future prostate cancer study.  Different tomato 
and broccoli powders were produced agronomically, and profiled for their bioactive content 
including levels of carotenoids, glucosinolates, isothiocyanates, and selenium.  In vivo exposure 
to bioactives was assessed by measurement of tissue carotenoid content and urinary SF 
metabolites.  Our primary measure of bioactivity was phase I and phase II detoxification enzyme 
activity.  We chose the phase I enzyme ethoxyresorufin O-deethylase (EROD) as reflective of 
any upregulation of cytochrome P450 1A and NAD(P)H-quinone oxidoreductase 1 (NQO1) as 
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reflective of any Nrf2-dependent upregulation of phase II enzymes (8)  We also measured the 
phase II enzyme glutathione S-transferase P1 (GSTP1), which is associated with appearance of 
pre-neoplastic foci and has previously not always responded in concert with other Nrf2-
dependent phase II enzymes (9).  Markers of androgen metabolism were also assessed because 
androgens play a key role in the development and progression of prostate cancer. 
 
MATERIALS AND METHODS 
Tomato and broccoli powders.  Standard tomato powder, lycopene-enriched tomato 
powder, standard broccoli floret powder (referred to as “standard broccoli”), and broccoli sprout 
powder were obtained from FutureCeuticals (Momence, IL).  Tomato powders were produced by 
grinding and pureeing the tomatoes, drum drying, and grinding the powder through a USA #20 
screen (equivalent to particle size of 0.85 mm).  To produce the broccoli floret powder, broccoli 
(Brassica olerea var. Monaco) was cut and diced to produce a floret, blanched, freeze dried, and 
ground through a USA #20 screen.  For the broccoli sprout powder, 3-day old broccoli sprouts 
(Brassica olerea var. Calabrese) were blanched, macerated and ground, drum dried, and ground 
through a USA #20 screen.  In addition, carotenoid-enriched tomatoes, indole glucosinolate-
enriched broccoli, and selenium-enriched broccoli were grown by Dr. Gary Bañuelos at the 
USDA-ARS research facility in Parlier, CA from March to July, 2007.  For the California-grown 
crops, normal agronomic management practices were applied on the test plots including pre-
plant application of fertilizer, insect and animal control, and hand weeding.  Broccoli (Brassica 
olerea var. Magestic) and tomatoes (Lycopersicum esculentum var. APT 410) were started and 
maintained in a commercial hot house.  Six to eight weeks later, tomato and broccoli seedlings 
were transplanted into experimental beds.  To produce indole glucosinolate-enriched broccoli, 
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treatment consisted of the plant hormone methyl jasmonate (1 mg/mL solution) in a 2% ethanol 
0.1% Triton x-100 aqueous solution sprayed on individual plants 7 days prior to harvest.  To 
produce selenium-enriched broccoli, selenium was applied as a sodium selenate solution of 10 
mg Se/L to the soil beneath each plant every two days beginning at day 45 after transplanting.  
Both broccoli, harvested 2 inches below the floret, and tomatoes, selected for bright red fruit, 
were dehydrated at a commercial dehydrator where they were blanched 4-5 minutes, cut, and 
dried at 110C for 24 h to a moisture level of 5%.  The product was then shipped to the 
University of Illinois in dry, opaque plastic bags.  Upon receipt, the dried vegetables were stored 
at 4C, and then processed into a powder using a hammermill (model 10; C.S. Bell Co., Tiffin, 
OH). 
Glucosinolate Analysis.  Intact glucosinolates were analyzed by modification of the 
method of Kushad et al. (10).  Freeze-dried broccoli powder (0.2 g) was placed in an Oak Ridge 
tube (Nalgene, Rochester, NY) and heated on a heating block at 95°C for 10 min. To each tube, 2 
mL of boiling 70% methanol were added and heated for an extra 10 min. After cooling on ice, 
0.5 mL benzylglucosinolate (1 mM) was added, mixed, and centrifuged at 12,000 x g for 15 min 
at 4 °C. The supernatant (extract) was saved and the pellet was re-extracted with 2 mL 70% 
methanol and the extracts combined.  A sample (1 mL) from each pooled extract was transferred 
into a glass tube. Protein was precipitated with 0.15 mL of a 1:1 mixture of 1 M lead acetate and 
1 M barium acetate. Each sample was then loaded onto a DEAE Sephadex A-25 column for 
desulfation with arylsulfatase for 18 h.  Desulfated glucosinolates were eluted from the column 
with water and injected onto a Lichosphere RP-18 column (Alltech Inc., Springfield, KY).  
Desulfoglucosinolates were eluted using a linear gradient of 1-40% acetonitrile in water at a flow 
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rate of 1mL/min over 40 minutes. Benzylglucosinolate (C2 Bioengineering Company, Denmark) 
was used as an internal standard. 
Isothiocyanate extraction and analysis.  Broccoli powders were suspended in water (50 
mg/mL) for 24 h at room temperature away from light to facilitate glucosinolate hydrolysis. 
Slurries were centrifuged at 16,000 x g for 10 min and supernatants were filtered through 0.45 
μm nylon membranes. Benzyl isothiocyanate (0.1 mg/mL DMSO) or 4-methoxyindole (0.1 
mg/mL DMSO) was used as an internal standard to a final concentration of 2 μg/mL for analysis 
of SF or I3C, respectively. Each supernatant was extracted with an equal volume of 
dichloromethane. One volume of DMSO was added to 5 volumes of dichloromethane extract, 
which was removed under a stream of nitrogen gas, leaving the sample in DMSO. 
 SF and I3C were analyzed by reverse-phase HPLC with UV detection at wavelengths of 
254 and 280 nm, respectively (Waters, Milford, MA). Fifty μL of the extract in DMSO sample 
was injected onto a Luna reverse-phase C18 column (5 μm, 250 x 4.6 mm, Phenomenex, 
Torrance, CA).  At a flow rate of 1 mL/min, 20% acetonitrile in water was increased linearly to 
100%, over 15 min.  The mobile phase was then maintained for 5 min, and returned to initial 
conditions at which the column was re-equilibrated for 10 min.  Solvents contained 1% (v/v) 
glacial acetic acid. Using Empower Pro software (Waters, Milford, MA), quantification was 
performed by comparison to SF and I3C standards (LKT Laboratories, St. Paul, MN). 
Selenium Analysis.  Selenium content of vegetable powders was measured by 
instrumental neutron activation analysis at the University of Missouri-Columbia Research 
Reactor Center by inducing Se-77m and measuring photon emissions associated with its decay.  
A standard reference material (SRM 1577, Bovine Liver), certified for selenium at 1.1  0.1 ppm 
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and supplied by the National Institutes for Standards and Technology, was analyzed in replicate 
as a quality control material. 
Carotenoid extraction and quantification.  Carotenoid extraction and analysis was 
performed as previously described (11).  Briefly, 0.1 g powder or 0.1 g tissue were combined 
with 6 mL KOH/ethanol solution (1:5) containing 0.1% BHT.  Samples were saponified at 60C 
for 30 min.  Samples were then placed on ice and deionized water was added.  Powder and tissue 
carotenoids were extracted 3 times with the addition of 6 mL of hexane.  Hexane extracts were 
dried in a Speedvac evaporator (model AS160; Savant, Farmingdale, NY), flushed with argon, 
and stored at -20C for 48 h prior to HPLC-PDA analysis.  All carotenoid extracts were kept on 
ice and under yellow lights throughout the extraction process. 
 Carotenoid concentrations in powders and tissues were analyzed by a reverse-phase 
HPLC-PDA system previously described (12).  All analyses were performed in duplicate, and 
the quantification of carotenoid isomers was carried out by comparing the UV spectra and 
retention times to analytical standards of phytoene, phytofluene, lycopene, and -carotene (gifts 
from Hansgeorg Ernst, BASF, Ludwigshafen, Germany). 
Animals and Experimental Design.  The University of Illinois Animal Care and Use 
Committee approved the animal protocol.  Sixty-four male Copenhagen rats (Cop 2331; Harlan, 
Indianapolis, IN) were obtained at ~ 8 weeks of age and individually housed in wire-bottom 
cages under controlled conditions (12 h light-dark cycle, 22C, 60% humidity).  Rats were 
weighed daily throughout the study.  Rats were provided with AIN-93G powdered diet and 
acclimated for 7 days.  On day 7, rats were randomly assigned to 8 experimental groups (n=8).  
AIN-93G based experimental diets included: AIN-93G control, 10% standard tomato powder, 
10% lycopene-enriched tomato powder, 10% carotenoid-enriched tomato powder, 10% standard 
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broccoli floret powder, 10% broccoli sprout powder, 10% IG-enriched broccoli powder, or 10% 
selenium-enriched broccoli powder.  Diets were balanced for protein, fat, energy, and fiber.  Diet 
formulations are shown in Table 2.1.  Food intake was measured daily.  Animals were pair-fed 
experimental diets for 7 days. 
Urinary analysis of sulforaphane conjugates.  For the last 24 h of experimental 
feeding, urine was collected into 50 mg ascorbic acid and stored at -80 C until analyzed.  SF and 
erucin N-acetylcysteine conjugates were quantified by HPLC-UV at a wavelength of 254 nm, as 
previously described (13).   Intake of glucoraphanin was calculated from broccoli hydrosylate 
analysis and average food intake (14.5  0.4 g per animal per day). 
Preparation of microsomal and cytosolic fractions. Rats were euthanized by CO2 
asphyxiation and tissues were taken.  Livers were perfused via the portal vein with cold 1.15% 
KCl. Colons were flushed with cold 1.15% KCl and mucosal scrapings of the proximal 5 cm 
were collected. Tissues were snap-frozen in liquid nitrogen and stored at -80 C until use. Liver 
and colon mucosal samples were thawed on ice, homogenized in 3 and 1 mL cold 0.05 M Tris-
HCl buffer (pH 7.4), respectively, and centrifuged for 20 min at 10,000 x g at 4 C. Colonic 
mucosal supernatant was stored at -80C until use; liver supernatant was further centrifuged for 
60 min at 100,000 x g at 4 C. The supernatant (cytosolic fraction) was stored at -80C until use 
and the pellet (microsomal fraction) was resuspended in 1 mL cold 0.05 M Tris-HCl buffer (pH 
7.4) containing 0.25 M sucrose, then stored at -80C until use. 
Detoxification enzyme activity. Activity of phase I enzyme CYP1A was measured in 
the microsomal fraction as ethoxyresorufin O-deethylase (EROD) activity (14) with slight 
modification (15).   Activity of cytosolic phase II enzyme NAD(P)H-quinone oxidoreductase 1 
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(NQO1) was measured according to the method of Prochaska and Santamaria (16) with 
modification (15).  
Serum testosterone measurements.  Serum testosterone was quantified using a coated 
tube radioimmunoassay kit (Diagnostic Systems Laboratory Inc., Webster, TX). 
Real-time quantitative PCR.  Total RNA was prepared from tissues using Trizol 
(Invitrogen, Carlsbad, CA) per the manufacturer’s instructions.  cDNA was synthesized using the 
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA).  mRNA 
expression of selected genes was measured via real-time PCR using SYBR Green Master Mix 
(Applied Biosystems, Foster City, CA).  Reactions were monitored by an ABI Prism 7900HT.  
Primer pairs were designed to measure steroid 5--reductase 1 (SRD5A1) (17), 5--reductase 2 
(SRD5A2) (18), glutathione-S-transferase  1 (GSTP1, NM_012577) forward-5’-
CCTATGTGGCTCGCCTCAGT-3’ and reverse-5’-GATGGGACGGTTCAAATGGT-3’ and 
ribosomal protein L7a (RPL7A, NM_001114391) forward-5’-
GAGGCCAAAAAGGTGGTCAATCC-3’ and reverse-5’-CCTGCCCAATGCCGAAGTTCT-
3’.  A validation experiment was performed on each set of primers (MWG Biotech, Huntsville, 
AL) to confirm efficiency and product specificity.  RPL7A was used as a housekeeping gene 
(19).  Relative mRNA abundance was determined using the comparative critical threshold 
method.  
Statistical analysis.  Data were compared among treatments by two-tailed analysis of 
variance, using SAS Statistical Software (version 9.1; SAS Institute, Cary, NC), and values were 
considered different from controls at P < 0.05 using Fisher’s least significant difference 
procedure. 
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RESULTS AND DISCUSSION 
Powder Characterization.  Here we demonstrate that tomato and broccoli powders with 
differing levels of bioactives can be readily produced by agronomic means and that this leads to 
altered uptake of bioactives in vivo.  We obtained tomato powders with enhanced levels of 
lycopene or total carotenoids, and broccoli powders with enhanced levels of glucosinolates or 
selenium.  Broccoli powders were analyzed for glucosinolate, SF, I3C, and selenium content 
(Table 2.2).  Glucoraphanin levels were similar among all broccoli except the broccoli sprout 
powder, which were 7 times greater.  As expected, SF content from dietary glucoraphanin was 
highest from the broccoli sprouts, being 23 times greater than in standard broccoli.  
Glucobrassicin was significantly higher in the indole glucosinolate-enriched broccoli, as 
expected.  The indole glucosinolate-enriched broccoli also had increased neoglucobrassicin 
levels.  Surprisingly, neoglucobrassicin levels were dramatically increased in the selenium-
enriched broccoli, by approximately 6 times compared to standard broccoli powder.  Broccoli 
sprouts had a low indole glucosinolate content.  Following hydrolysis, indole glucosinolate-
enriched broccoli contained slightly lower levels of I3C than standard broccoli (P<0.05). 
Tomato powders were analyzed for carotenoid content (Table 2.3).  Levels of lutein, 
zeaxanthin, -carotene, and -cryptoxanthin were all below 5 nmol/g (data not shown). 
Lycopene-enriched tomato powder had similar levels of phytoene, phytofluene, and -carotene 
compared to standard tomato powder, but it also had approximately 2.6 times more lycopene 
than the standard tomato powder.  The carotenoid-enriched tomato powder contained total 
carotenoid levels approximately 3.4 times greater than the standard tomato powder and 2 times 
greater than lycopene-enriched tomato powder. 
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Diet and Weight Gain.  The group of rats receiving the selenium-enriched broccoli diet 
had the lowest food intake.  As a result, all other animals were pair-fed to this group.  Each day 
other diet groups received the amount of diet equal to the average amount consumed by the 
selenium-enriched broccoli group the day before.  The average amount of food consumed daily 
was 14.5  0.4 g.   Rats gained weight as expected throughout the study, and there were no 
significant differences in final body weight between groups.  The estimated daily intake of 
glucoraphanin from the broccoli powders was 4.4, 31.3, 3.6 and 4.9 μmol for standard broccoli, 
broccoli sprouts, indole glucosinolate-enriched broccoli and selenium-enriched broccoli, 
respectively (Figure 2.1).  The estimated daily intake of lycopene from the tomato powders was 
249, 647, and 879 nmol for standard tomato, lycopene-enriched tomato, and carotenoid-enriched 
tomato, respectively. 
Sulforaphane Metabolism.  Sulforaphane is metabolized primarily via the mercapturic 
acid pathway (20), and SF-NAC is used as a marker for fractional absorption of this 
isothiocyanate (21).  Urinary levels of sulforaphane N-acetylcysteine conjugates (SF-NAC) are 
shown in Figure 2.1.  The reduced form, erucin N-acetylcysteine, was below the level of 
detection.  Recovery of SF-NAC was significantly greater in the broccoli sprout group.  Percent 
recovery of SF-NAC from ingested glucoraphanin was 4% for standard broccoli, 49% for 
broccoli sprouts, 28% for indole glucosinolate-enriched broccoli, and 12% for selenium-enriched 
broccoli.  The enhanced urinary content of SF from sprouts is consistent with individual data for 
sprouts and standard broccoli from the literature (13, 22).  However, early hydrolysis before 
digestive enzymes destroy broccoli myrosinase cannot explain this, since in the past pre-
hydrolyzing broccoli did not enhance SF-NAC yield (13).  Blanching of the sprouts may have 
destroyed the myrosinase cofactor that directs glucoraphanin hydrolysis to nitrile formation in 
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place of SF (23).  This idea is consistent with the far greater yield of SF from glucoraphanin in 
sprouts compared to standard broccoli (Table 2.2). 
Hepatic Carotenoid Accumulation.  Liver carotenoid content is shown in Table 2.4.  
Interestingly, hepatic carotenoid accumulation did not strictly follow the patterns seen in the 
tomato powder carotenoid profiles.  The carotenoid-enriched tomato powder had carotenoid 
levels 2-3 times greater than standard tomato powder, but only the hepatic accumulation of 
phytoene and -carotene was significantly increased compared to standard tomato powder.  The 
lycopene-enriched tomato group had the expected significantly higher levels of lycopene but also 
significantly lower levels of phytofluene and phytoene compared to standard and carotenoid-
enriched tomato powders.  
The lower than expected accumulation level of lycopene and phytofluene from feeding 
the carotenoid-enriched tomato powder may have been due to differences in processing method.  
The commercial tomato powders (standard and lycopene-enriched) were more finely ground than 
powders grown in California which were processed using a hammermill (carotenoid-enriched 
tomato powder), possibly leading to an increase in hepatic accumulation.  Alternatively, there is 
literature indicating that supplementation of a normal diet with -carotene supplements or -
carotene rich foods may lead to a decrease in serum lycopene (24, 25).  The higher levels of 
phytoene and -carotene in the carotenoid-enriched tomato powder could compete with lycopene 
for absorption and transport.  Lycopene-enriched tomato powder feeding resulted in significantly 
higher hepatic levels of lycopene than standard tomato powder, but it also resulted in 
significantly reduced uptake of phytoene and phytofluene.  These data support the possibility that 
there may be competition between carotenoids for absorption pathways. 
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Indole Glucosinolate Metabolism.  High doses of purified I3C are rapidly degraded in 
the body.  Serum levels of I3C have been reported to fall below detectable levels (0.05 g/mL 
measured by HPLC) within an hour after oral administration to mice (250 mg/kg) (26).  
Similarly in humans, I3C was not detectable in serum one hour after oral administration (400 
mg) with a limit of detection of 1.0 ng/mL (measured by HPLC-MS) (27).  The dose provided 
here by a 10% indole glucosinolate-enriched broccoli diet is approximately 1000-fold lower than 
the levels used in the above pharmacokinetic studies and would likely not be detectable, 
particularly since rats were fed ad libitum rather than a bolus dose of the compound. 
Detoxification Enzyme Activity.  Broccoli and its glucosinolate hydrolysis products 
have been shown to induce phase I and phase II drug-metabolizing enzymes (13).  Detoxification 
enzymes in the colon and liver play an important role in the metabolism and clearance of 
carcinogens.  Xenobiotics are oxidatively metabolized by phase I enzymes generating products 
which are potentially carcinogenic.  Phase II conjugating enzymes are then able to add polar 
molecules (glutathione, glucuronide, sulfate, etc.) to the metabolite, enhancing water solubility.  
These products are more easily eliminated from the body.  Therefore the balance between 
activating (phase I) and detoxifying (phase II) reactions is an indication of the risk of ultimate 
carcinogen available for reaction with cellular DNA.  Here we demonstrate that broccoli 
enriched with bioactive components through agronomic practices enhance both CYP1A and 
NQO1 activity in liver and colon to a greater extent than standard broccoli.  
Tissue enzyme activities of EROD and NQO1 are shown in Figure 2.2A, B, and C.  The 
standard broccoli diet did not alter EROD or NQO1 in liver but did increase NQO1 in the colon.  
SF-rich broccoli sprouts showed no hepatic EROD induction, but increased NQO1 1.9 times in 
the liver and 2.3 times in the colon (P<0.05).  Indole glucosinolate-enriched broccoli increased 
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hepatic EROD and NQO1 activity 1.4 and 1.3 times, respectively, and colon NQO1 1.6 times 
(P<0.05).  Selenium-enriched broccoli induced hepatic EROD 1.8 times; NQO1 was elevated 2.2 
and 1.8 times in the liver and the colon, respectively (P<0.05).  No differences in EROD or 
NQO1 were observed between groups receiving the tomato powder diets.  Lycopene-enriched 
tomato and standard broccoli diets decreased glutathione S-transferase P1 (GSTP1) mRNA 
levels by 23.3% and 31.9%, respectively compared to the control diet (P<0.05) (Figure 2.3). 
Glucobrassicin and neoglucobrassicin, as well as their respective hydrolysis products I3C 
and N-methoxyindole-3-carbinol (NI3C), are known to induce CYP1A (28-31).  Although 
neoglucobrassicin is a weaker inducer than glucobrassicin in vivo, a mixture containing both 
glucosinolates showed strongest induction of hepatic CYP1A (29).  In concordance, indole 
glucosinolate-enriched broccoli and selenium-enriched broccoli increased hepatic CYP1A-
dependent EROD activity.  Neither standard broccoli nor broccoli sprouts altered hepatic 
CYP1A activity, which correlates with their low levels of neoglucobrassicin and I3C. 
Broccoli sprouts, indole glucosinolate-enriched and selenium-enriched broccoli increased 
NQO1 in both liver and colon.  Standard broccoli effectively upregulated NQO1 in the colon, but 
it did not significantly upregulate enzymes in the liver, possibly because the dose of SF was 
insufficient.  This tissue-specific effect suggests incomplete myrosinase-dependent hydrolysis of 
glucoraphanin in the upper gut, resulting in hydrolysis in the lower gut and subsequent local 
increase in NQO1 (15). 
The relative amounts of SF in standard broccoli, broccoli sprout and indole glucosinolate-
enriched broccoli (1.0, 22.8 and 1.7 μmol SF/g dry weight, respectively) elicited an increase in 
NQO1 activity in liver (20, 90 and 30%, respectively) and colon (20, 130 and 60%, respectively) 
that was proportional to the SF dose.  Selenium-enriched broccoli induced enzyme activity to a 
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greater extent than can be ascribed to its SF level.  Broccoli accumulates selenium primarily as 
Se-methylselenocysteine (32), which alone or in synergy with SF may account for the increase in 
NQO1 activity.  These data are in contrast to those of Robbins et al. (33), who reported a 
suppression of SF levels in broccoli treated with a sodium selenate solution (100 or 10,000 ppm).  
This resulted in very high levels of selenium in broccoli (up to 800 ppm).  The freeze-dried 
broccoli used here had 4 ppm Se, which would have been ~0.4 ppm in the fresh plant. 
In contrast to feeding standard broccoli, which resulted in greater increases in NQO1 in 
the colon than in the liver, feeding selenium-treated broccoli resulted in larger increases in 
NQO1 in liver than in colon.  One possible cause for this is that hepatic metabolism permitted 
the formation of a more potent metabolite.   
Prostate cancer is characterized by loss of GSTP1 expression, regardless of the grade or 
stage of the disease (34).  Unexpectedly, broccoli florets and lycopene-enriched tomato 
significantly reduced GSTP1 expression by 32% and 23%, respectively.  These results appear to 
contradict previous evidence showing that lycopene partially demethylates the GSTP1 promoter 
and restores expression in breast cancer cells (35) and that oral intake of SF increases GSTP1 
expression in nasal mucosa (36).  The family of GST enzymes are not all regulated similarly and 
GSTP1 has previously been found to lack the inductive response to dietary crucifers seen for 
GSTM1 and GSTA1 (9). 
Androgen Metabolism.  Previous reports suggest that androgen metabolism might be 
altered by tomato and/or lycopene feeding.  Our own lab has shown that 4-day feeding of 
lycopene or tomato powder resulted in significantly reduced levels of serum testosterone in 
Fisher 344 rats (18).  It has also been reported that lycopene feeding decreased prostatic mRNA 
levels of SRD5A2 (37), which is a key enzyme in the conversion of testosterone to the more 
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potent androgen, dihydroxytestosterone.  In the current study, no significant alterations were 
seen in either serum testosterone levels (values ranged from 0.54 – 1.78 ng/mL) or mRNA levels 
of SRD5A1 or SRD5A2 (data not shown).  The lack of significant reduction in serum 
testosterone level may be due to the longer feeding period (7 vs. 4 days) or the strain of rat used.  
Reduction in expression of SRD5A2 has been seen in Copenhagen rats of a similar age (37).  
However, in that study rats were fed supplemental lycopene for a period of 8 weeks, resulting in 
a much longer and higher dose lycopene exposure than the present study.  As noted above, 
alterations in serum testosterone were reported for Fisher 344 rats after 4 days of 10% tomato 
powder feeding (18), which is shorter than the 7 day feeding period used in this study, suggesting 
that the effects of tomato on serum testosterone levels could be a transient effect, or that the 
dose-response varies with strain.  None of the broccoli treatments had significant effects on 
androgen metabolism endpoints.  To our knowledge the effects of broccoli on testosterone 
metabolism have not been previously investigated, and these data demonstrate that broccoli 
feeding does not alter serum testosterone levels or expression of two key metabolizing enzymes. 
In summary, we have demonstrated that levels of bioactive components in tomatoes and 
broccoli can be altered through agronomic means.  This increase in bioactives in the vegetable 
can translate to increased tissue content and increased bioactivity in vivo.  These encouraging 
findings suggest that bioactive-enriched vegetables should be tested for cancer prevention. 
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Table 2.1.  AIN-93G based diet formulations. 
 
 g/100g total diet 
 Control Tomato 
(Std, Lyc, Car) 
Broccoli 
(Std, IG, Se) 
Broccoli 
(Sprout) 
Cornstarch 39.7 33.2 36.6 38.0 
Casein 20.0 18.7 16.8 16.9 
Maltodextrin 13.2 13.2 13.2 13.2 
Sucrose 10.0 10.0 10.0 10.0 
Fiber* 5.0 3.3 1.6 3.4 
Mineral mix** 3.5 3.5 3.5 3.5 
Vitamin mix*** 1.0 1.0 1.0 1.0 
L-Cystine 0.3 0.3 0.3 0.3 
Choline bitartrate 0.3 0.3 0.3 0.3 
Soybean oil 7.0 6.5 6.7 5.3 
Tomato powder  10.0   
Broccoli powder   10.0 10.0 
 
*Non-nutritive cellulose 
**AIN93M-MX formulation 
***AIN93-VX formulation 
 
43 
Table 2.2.  Glucosinolate, isothiocyanate, and selenium profile of broccoli powders. 
 
 mol/g dry weight 
 Standard 
Broccoli  
Broccoli sprout IG-enriched 
Broccoli 
Se-enriched 
Broccoli 
Glucoraphanin 3.05  0.36 b 21.60  4.30 a 2.46  0.36 b 3.36  0.55 b 
Glucobrassicin 2.17  0.06 b 0.05  0.00 d 3.27  0.17 a 0.73  0.05 c 
Neoglucobrassicin 1.97  0.06 c 0.06  0.00 d 3.74  0.02 b 11.99  0.75 a 
Sulforaphane 0.98  0.02 b 22.78  1.30 a 1.73  0.11 b 1.75  0.13 b 
Indole-3-Carbinol 0.10  0.01 a 0.04  0.00 c 0.08  0.00 b 0.10  0.01 a 
     
 ppm 
Selenium 0.25 0.06 0.06 4.28 
 
Values are means  SEM, n=2-4 (where n=2, SEM is not reported).  Different superscript letters 
within rows indicate significant differences between treatments (P<0.05). 
 
Table 2.3.  Carotenoid profile of tomato powders. 
 nmol/g 
 Standard  
Tomato 
Lycopene-enriched  
Tomato 
Carotenoid-enriched  
Tomato 
Phytoene 102  7 b 92   1 b 347  6 a 
Phytofluene 74  7 b 71  1 b 224  3 a 
-carotene 13  1 b 13  0 b 50  2 a 
cis lycopene 80  9 b 213  9 a 116  21 b 
all-trans & 5-cis 
lycopene 
92  11 c 233  16 b 490  66 a 
Total lycopene 172  21 b 446  24 a 606  87 a 
Total carotenoid* 
(g/g) 
195  19 c 335  14 b 663  52 a 
 
Values are means  SEM, n=3. Different superscript letters within rows indicate significant 
differences between treatments (P<0.05). 
*Total carotenoid = phytoene + phytofluene + -carotene + total lycopene
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Table 2.4.  Hepatic Carotenoid Content. 
 
 g/g 
 Standard  
Tomato 
Lycopene-enriched  
Tomato 
Carotenoid-enriched  
Tomato 
Phytoene 13.0  0.7 b 8.7  0.6 c 19.4  0.7 a 
Phytofluene 13.0  0.4 a 9.8  0.7 b 13.4  0.5 a 
-carotene 0.2  0.0 b 0.2  0.0 b 0.3  0.0 a 
Lycopene 18.4  1.5 b 26.7  2.4 a 19.1  0.9 b 
Total carotenoid* 44.4  2.1 b 45.1  3.1 b 52.0  1.5 a 
 
Values are means  SEM, n=8.  Each sample was run in duplicate. 
*Total carotenoid = lycopene + phytofluene + phytoene + -carotene.   
Different superscript letters within a row indicate significant differences between treatments (P 
<0.05). 
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Figure 2.1. Estimated daily glucoraphanin (GRP) intake (  ) and 24 hour urinary SF-NAC 
excretion (  ) on the last day of a 7 day feeding period.  Experimental groups are as follows: B-
Std = standard broccoli, B-Sp = broccoli sprout, B-IG = indole glucosinolate-enriched broccoli, 
B-Se = selenium-enriched broccoli. Results shown are means  SEM, n=8.  Samples were run in 
triplicate.  Different letters above bars indicate significant differences between treatments (P 
<0.05). 
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Figure 2.2.  A: Liver EROD, B: Liver NQO1, C: Colon NQO1 after 7-day feeding period.  
Experimental groups are as follows: C = control, T-Std = standard tomato, T-Lyc = lycopene-
enriched tomato, T-Car = carotenoid-enriched tomato, B-Std = standard broccoli, B-Sp = 
broccoli sprout, B-IG = indole glucosinolate-enriched broccoli, B-Se = selenium-enriched 
broccoli.  Results shown are means  SEM, n=8.  Samples were run in triplicate.  For each 
enzyme, different letters above bars indicate significant differences between treatments (P 
<0.05).  
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Figure 2.3.  Gene expression of prostatic GSTP1 after 7-day feeding.  AU = arbitrary units.  
Experimental groups are as follows: C = control, T-Std = standard tomato, T-Lyc = lycopene-
enriched tomato, T-Car = carotenoid-enriched tomato, B-Std = broccoli, B-Sp = broccoli sprout, 
B-IG = indole glucosinolate-enriched broccoli, B-Se = selenium-enriched broccoli.  Results 
shown are means  SEM, n=8.  Different letters above bars indicate significant differences 
between treatments (P <0.05). 
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CHAPTER 3 
 
METHYL JASMONATE-TREATED BROCCOLI AND PROSTATE 
CARCINOGENESIS IN TRAMP MICE1 
 
ABSTRACT 
Broccoli is rich in bioactive components that may impact cancer risk, such as sulforaphane and 
indole-3-carbinol.  The glucosinolate profile of broccoli can be manipulated through treatment 
with the plant stress hormone, methyl jasmonate (MeJa) to increase levels of indole 
glucosinolates.  Our objective was to determine if feeding standard broccoli (Brassica oleracea 
var. Green Magic), or the same variety of broccoli treated with MeJa during growth, would 
impact prostate carcinogenesis in the aggressive TRAMP model.  MeJa treatment significantly 
increased levels of glucobrassicin, neoglucobrassicin, and gluconasturtiin (P < 0.05).  Male 
TRAMP mice (n=99) were randomized into 3 diet groups at 5-7 weeks of age: AIN-93G control, 
10% standard broccoli powder, or 10% MeJa broccoli powder.  Diets were fed throughout the 
study until termination at 20 weeks of age.  Neither broccoli treatment significantly altered 
genitourinary tract weight, pathologic score, proliferation or apoptosis indicating that broccoli 
feeding did not reduce prostate carcinogenesis in the TRAMP model. 
 
INTRODUCTION 
Epidemiological studies provide moderate support for the hypothesis that consumption of 
cruciferous vegetables reduces the risk of developing prostate cancer (1).  Broccoli is the most 
commonly consumed cruciferous vegetable in the United States with the average American 
eating 8.6 pounds of fresh broccoli and broccoli products each year (2).  Broccoli contains many 
                                                
1 This chapter was the result of a collaboration between the following authors: Ann G. Liu, Lisa 
D. Berman-Booty, Steven K. Clinton, Elizabeth H. Jeffery, and John W. Erdman, Jr. 
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glucosinolates including glucoraphanin, the precursor to the anti-carcinogenic compound, 
sulforaphane, glucobrassicin, which is hydrolyzed to indole-3-carbinol (I3C) in the 
gastrointestinal tract, and neoglucobrassicin, which is hydrolyzed to N-methoxy-I3C.  
Sulforaphane and I3C are known to have anti-carcinogenic properties (3, 4), but studying these 
compounds in isolation may obscure and additive or synergistic actions that might take place 
when a whole vegetable is consumed.   
 Our lab had previously shown that feeding whole tomato or broccoli powder significantly 
reduced tumor growth in a rat transplantable tumor model of prostate cancer whereas pure 
lycopene alone did not, suggesting that the whole vegetable is indeed more effective than an 
individual bioactive (5).  In a previous study, our lab also demonstrated that we could increase 
the levels of specific bioactives within whole tomatoes and broccoli using agronomic means (6).  
Finley et al. demonstrated that selenium-enriched broccoli was more effective than high doses of 
selenite alone or a combination of selenite and broccoli sprout powder for reducing the formation 
of aberrant crypt foci in a rat model of colon cancer (7).  That study lends support to the 
hypothesis that optimizing the bioactive content of whole broccoli may enhance potential for 
cancer prevention. 
 Glucosinolates are divided into three classes based on the amino acid precursors from 
which they originate.  Aliphatic glucosinolates are derived from methionine, indole 
glucosinolates from tryptophan, and aromatic glucosinolates from phenylalanine.  These 
phytochemicals are constitutively present in cruciferous plant tissues, but they can also be 
rapidly induced by stresses such as wounding, pathogens, or herbivore attacks.  These stress 
conditions lead to the endogenous biosynthesis of jasmonates, which induce the synthesis of 
indole glucosinolates (8).  External application of methyl jasmonate, a volatile methylester of 
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jasmonate, has been shown to induce production of indole glucosinolates in Brassica species (9, 
10).  Methyl jasmonate treatment offers a way of altering the phytochemical profile of broccoli 
to increase concentrations of potentially anti-carcinogenic bioactives. 
 Here we examined the effects of standard broccoli and MeJa-treated broccoli on prostate 
carcinogenesis in TRAMP mice.  We hypothesized that both broccoli treatments would reduce 
prostate carcinogenesis and that MeJa-treated broccoli would further reduce carcinogenesis 
compared to standard broccoli.  To our knowledge, this is only the second study to examine the 
effects of whole broccoli in an animal model of prostate cancer; the first utilized the Dunning rat 
model (5). 
 
MATERIALS AND METHODS 
Broccoli Powder Production. Broccoli (Brassica oleracea var. Green Magic) was 
grown on the University of Illinois campus in Urbana, IL from May through August 2009.  
Broccoli plants were started and maintained in a commercial hot house for 3 weeks.  Before 
transplanting to experimental fields, broccoli seedlings were hardened outside for one week.  To 
produce indole glucosinolate-enriched broccoli, treatment consisted of the plant hormone methyl 
jasmonate (250 µM) in a 0.1% Triton X-100 aqueous solution sprayed on individual plants 4 
days prior to harvest.  Plant surfaces were fully saturated with MeJa, allowed to dry, and then 
received an additional application of MeJa.  Broccoli was harvested at commercial size with 
some stem, frozen in liquid nitrogen, and stored at -20°C until freeze-dried.  After freeze-drying, 
broccoli samples were finely ground using a commercial coffee grinder. 
Glucosinolate Analysis.  Intact glucosinolates were analyzed by modification of the 
method of Kushad et al. (11).  Freeze-dried broccoli powder (0.2 g) was placed in an Oak Ridge 
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tube (Nalgene, Rochester, NY) and heated on a heating block at 95°C for 10 min. To each tube, 2 
mL of boiling 70% methanol were added and heated for an extra 10 min. After cooling on ice, 
0.5 mL benzylglucosinolate (1 mM) was added, mixed, and centrifuged at 12,000 x g for 15 min 
at 4 °C. The supernatant (extract) was saved and the pellet was re-extracted with 2 mL 70% 
methanol and the extracts combined.  A sample (1 mL) from each pooled extract was transferred 
into a glass tube. Protein was precipitated with 0.15 mL of a 1:1 mixture of 1 M lead acetate and 
1 M barium acetate. Each sample was then loaded onto a DEAE Sephadex A-25 column for 
desulfation with arylsulfatase for 18 h.  Desulfated glucosinolates were eluted from the column 
with water and injected onto a Lichosphere RP-18 column (Alltech Inc., Springfield, KY).  
Desulfoglucosinolates were eluted using a linear gradient of 1-40% acetonitrile in water at a flow 
rate of 1mL/min over 40 minutes. Benzylglucosinolate (C2 Bioengineering Company, Denmark) 
was used as an internal standard. 
 Animals and Experimental Design.  The University of Illinois Animal Care and Use 
Committee approved the animal protocol.  Ninety-nine male TRAMP mice on a pure C57BL/6 
background (C57BL/6-Tg(TRAMP)8247Ng/J; The Jackson Laboratory, Bar Harbor, ME) were 
obtained at 5-7 weeks of age and individually housed in shoe-box cages under controlled 
conditions (12 h light-dark cycle, 22°C, 60% humidity).  Mice were weighed weekly throughout 
the study.  Mice were randomly assigned to 3 experimental groups (n=33).  AIN-93G based 
experimental diets included: AIN-93G control, 10% control broccoli powder, or 10% MeJa-
treated broccoli powder.  Diets were balanced for protein, fat, energy, and fiber.  Diet 
formulations are shown in Table 3.1.  Food was replaced and intake was measured every other 
day.  Fresh diets were prepared monthly.  Mice were sacrificed at 20 wks of age.  At the 
conclusion of the study, mice were asphyxiated by CO2 and blood was collected by cardiac 
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puncture.  Lungs, liver, and genitourinary tract were removed and weighed.  The prostate was 
microdissected when possible and individual lobes were weighed and preserved in 10% formalin 
for histology. Lungs and sections of each liver lobe were also preserved in 10% formalin for 
histology. 
Preparation of microsomal and cytosolic fractions.  Livers were perfused via the 
portal vein with cold 1.15% KCl. Tissues were snap-frozen in liquid nitrogen and stored at -80 
°C until use. Liver samples were thawed on ice, homogenized in 3 and 1 mL cold 0.05 M Tris-
HCl buffer (pH 7.4), respectively, and centrifuged for 20 min at 10,000 x g at 4 °C.  Liver 
supernatant was further centrifuged for 60 min at 100,000 x g at 4 °C. The supernatant (cytosolic 
fraction) was stored at -80°C until use and the pellet (microsomal fraction) was resuspended in 1 
mL cold 0.05 M Tris-HCl buffer (pH 7.4) containing 0.25 M sucrose, then stored at -80°C until 
use. 
Detoxification enzyme activity. Activity of phase I enzyme CYP1A was measured in 
the microsomal fraction as ethoxyresorufin O-deethylase (EROD) activity (12) with slight 
modification (13).   Activity of cytosolic phase II enzyme NAD(P)H-quinone oxidoreductase 1 
(NQO1) was measured according to the method of Prochaska and Santamaria (14) with 
modification (13).  
Tissue Histology and Immunohistochemistry.  A section of each prostate lobe was 
preserved in 10% formalin for 24 hrs and then transferred to 70% ethanol.  Formalin-fixed 
tissues were embedded in paraffin, sectioned, and transferred to slides.  4 µm sections for 
histological evaluation were stained with hematoxylin/eosin. 
Pathologic grading was performed by trained pathologists at the Ohio State University 
who have extensive experience with transgenic mouse models of prostate cancer.  Each of the 
58 
four prostate lobes (dorsal, ventral, lateral, anterior) of C57BL/6 TRAMP mice was assessed 
individually and were assigned two grades each ranging from 0 to 7 (Table 3.2). The first grade 
represented the most severe lesion within that lobe, and the second grade identified the most 
common lesion in the lobe. Regarding the individual grade, grade 0 was normal prostate.  Grades 
1, 2, and 3 represented low, moderate, and high grade PIN, respectively. Grade 4 included 
papillary adenomas and phyllodes-like lesions. Grades 5 and 6 represented well and moderately 
differentiated adenocarcinomas, respectively. Grade 7 was poorly differentiated carcinoma.  The 
distributions of each of these lesions within the individual lobe were determined and described as 
focal, multifocal, or diffuse. Adjusting the lesion grades (0-7) to include an indication of 
distribution provided two adjusted scores, one for the most severe lesion and the other for the 
most common, ranging from 0 (normal) to 21 (diffuse poorly differentiated carcinoma). These 
adjusted scores were then added to obtain a sum that reflected the most severe lesion and its 
distribution and the most common lesion and its distribution (sum of the adjusted lesion scores). 
Four µm sections were stained for PCNA (Abcam, Cambridge, MA) and cleaved 
caspase-3 (Cell Signaling Technology, Danvers, MA).  Images were captured and quantified as 
previously described (5) with the researchers blinded to treatments.  Two representative images 
without necrosis or artifacts were captured for the dorsal and lateral lobes of the prostate.  For 
PCNA, a proliferative index percentage, (PCNA positive/total nuclei counted) x 100, was 
calculated.  For cleaved caspase-3 the number of apoptotic nuclei were counted at 400x 
magnification. 
Statistical analysis.  Data were compared among treatments by two-tailed analysis of 
variance, using the Mixed Models procedure of SAS Statistical Software (version 9.2; SAS 
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Institute, Cary, NC).  Values were considered different from controls at P < 0.05 using Tukey’s 
procedure. 
 
 
RESULTS AND DISCUSSION 
 Broccoli Powder Characterization.  Broccoli powders were analyzed for glucosinolate 
content (Table 3.3).  MeJa treatment significantly increased levels of glucobrassicin, 
neoglucobrassicin, and gluconastrurtiin (P<0.05).  Strikingly, neoglucobrassicin levels were over 
7 times higher in the MeJa broccoli than in the control broccoli.  This induction was much 
greater than what we had previously observed with a different variety of broccoli (Brassica 
oleracea var. Marathon) (6).  Glucoraphanin levels were similar in both broccoli powders. 
However, these levels are much lower than those found in broccoli sprouts which have very high 
levels of glucoraphanin and minor amounts of other glucosinolates (15). 
 Diet and Weight Gain.  Diets were well tolerated and there were no significant 
differences among groups in food intake or body weight (Table 3.4).  Two animals had to be put 
down prior to completion of the study for health reasons unrelated to cancer development.  On 
average mice consumed 5.1 ± 0.1 g per day.  The estimated daily intakes of glucoraphanin, 
glucobrassicin, and neoglucobrassicin per mouse were 1.2, 1.3, and 2.6 µmol for standard 
broccoli, and 1.8, 1.5, and 19.9 µmol for MeJa broccoli, respectively.  
Detoxification Enzyme Activity.  Broccoli and its glucosinolate hydrolysis products 
have been shown to induce phase I and phase II detoxification enzymes (16).  Glucobrassicin and 
neoglucobrassicin, as well as their respective hydrolysis products I3C and N-methoxyindole-3-
carbinol (NI3C), are known to induced CYP1A.  As expected, we observed a dose-dependent 
increase in CYP1A activity with increasing levels of indole glucosinolates in broccoli (Figure 
60 
3.1A).  MeJa broccoli feeding resulted in hepatic EROD activity 2.5 times greater than the 
control group (P<0.05).  Standard broccoli also significantly increased hepatic EROD activity 
but to a lesser magnitude, 1.5 times greater than control (P<0.05).   
Surprisingly, neither broccoli treatment increased hepatic NQO1 activity (Figure 3.1B).  
Sulforaphane is known to induce NQO1 activity, and broccoli has previously been documented 
to increase hepatic NQO1 activity in other studies (6, 16).  This lack of induction may have been 
due to the length of the study.  Previous studies showing hepatic induction of NQO1 were 7 days 
or fewer in length.  In contrast, the present study was approximately 15 weeks in length.  
Previous work in our lab found no alterations in hepatic NQO1 activity after male Copenhangen 
rats were fed a 10% broccoli powder diet for 22 weeks (unpublished data), suggesting that 
induction of NQO1 may be lost following long-term feeding. 
 Tissue weights.  Liver and genitourinary tract weights were not different among groups. 
Eleven animals developed visible prostate tumors, which engulfed the genitourinary tract: one in 
the control group, six in the standard broccoli group, and four in the MeJa broccoli group.  Mean 
genitourinary tract weights were 1.00, 1.25, and 1.25 g for control, standard broccoli, and MeJa 
broccoli groups, respectively (Figure 3.2).  Because genitourinary tract weight is a surrogate 
marker of tumor volume, these results indicate that broccoli feeding did not alter tumor growth.  
These results are in contrast to work by Keum et al. who demonstrated a significant decrease in 
genitourinary tract weight feeding an 8% broccoli sprout diet (17). 
 When possible, the prostate was microdissected into four individual lobes (ventral, 
lateral, dorsal, anterior) and each lobe was weighed.  Total prostate weight is the sum of these 
weights, and we observed a small but significant decrease in animals fed either broccoli powder 
(data not shown).  Mean prostate weights were: 0.136 g in the control group, 0.119 g  in the 
61 
broccoli group (P<0.05 vs. control), and 0.118 g in the MeJa broccoli group (P<0.05 vs. control, 
P=0.99 vs. broccoli).  However, these results are inconclusive because our sample was biased by 
the removal of animals that developed prostate tumors which engulfed the genitourinary tract.  
Because more animals were removed from the two broccoli groups, this would likely skew our 
sample to animals with smaller prostates. 
Proliferation and apoptosis.  There were no significant differences among groups in 
prostatic proliferation or apoptosis as measured via PCNA and cleaved caspase-3 (Figure 3.3).  
These findings are not surprising in light of our data showing no alterations in genitourinary tract 
weight.  Our values are within the normal range of proliferative index and apoptotic index values 
observed in TRAMP mice.  Previous studies have reported decreased proliferation when 
sulforaphane or DIM were administered via oral gavage (18, 19).  
Histology.  Prostate cancer progression varied by lobe as expected (20).  The lateral 
prostate had mostly diffuse well differentiated carcinomas while the dorsal prostate had 
predominantly diffuse high grade PIN.  Within each prostate lobe, no significant differences in 
adjusted lesion score were observed, indicating that broccoli feeding did not impact prostate 
cancer progression (Table 3.5).  This was surprising given that studies with sulforaphane, 3,3’-
diindolylmethane (DIM), PEITC, and broccoli sprouts had all shown reduced cancer progression 
in the TRAMP model (18, 19, 21)(E. Ho, personal communication, April 16, 2011).  Singh et al. 
observed reductions in the incidence of PIN and well differentiated (WD) carcinomas when 
TRAMP mice were gavaged with 6 µmol sulforaphane (18).  Cho et al. gavaged TRAMP mice 
with 3 µmol of DIM and saw increased incidence of PIN and decreased incidence of WD 
carcinoma, indicating a slowing of prostate cancer progression (19).  Powlony et al. reported 
decreased incidence of poorly differentiated (PD) cancers when TRAMP mice received 
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approximately 15 µmol of PEITC per day in their diet (21).  Additionally, an unpublished study 
from Dr. Emily Ho’s laboratory found that feeding a 15% broccoli sprout diet decreased 
incidence of WD carcinomas and increased incidence of PIN (personal communication, April 16, 
2011).  All studies varied in the treatment, delivery route, background strain, and age of mice at 
study termination making it difficult to directly compare results (Table 3.6 and 3.7).  However, 
the literature thus far seems to be supportive for the role of broccoli sprouts or sulforaphane in 
reducing prostate carcinogenesis, perhaps suggesting that high sulforaphane levels may be key to 
the beneficial effects of crucifers with indole glucosinolates being less influential.  Work by Cho 
et al. demonstrates that DIM, a breakdown product of the indole glucosinolate glucobrassicin can 
reduce prostate carcinogenesis (19), suggesting that indole glucosinolates can be effective, but it 
is unknown how the level of this pure compound compares to the dose formed upon 
consumption of whole broccoli. 
In the current study, mice received whole glucosinolates in the broccoli powder matrix.  
However, other studies have used pure glucosinolate hydrolysis products such as sulforaphane, 
DIM, and PEITC.  The formation of these glucosinolate hydrolysis products from glucosinolates 
depends on several factors including levels in the plant material, myrosinase activity, pH, and the 
stability of the compounds (22).  Thus it is difficult to directly compare glucosinolate levels with 
those of a pure compound, however we would speculate that conversion is not one hundred 
percent efficient.  The amount of glucosinolates consumed per day by the animals in this study 
are similar to levels in our previous study in the Dunning model (5).  However they are 2-8 times 
lower than the corresponding dose of glucosinolate hydrolysis product received by TRAMP mice 
in other reports (Table 3.7).  It is possible that there may be low conversion of glucosinolates to 
isothiocyanates from the  broccoli powder used in this study, and it would be useful to examine 
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hydrolysis product formation.  These discrepancies highlight the importance of considering 
dietary levels and the impact of chemical form when conducting studies with dietary bioactives. 
This is only the second study to evaluate the effects of whole broccoli on prostate cancer 
in an animal model.  In summary, neither broccoli treatment significantly reduced prostate 
carcinogenesis in TRAMP mice.  However, we had previously reported that whole broccoli with 
similar levels of glucosinolates was effective in reducing tumor growth in the Dunning R3327-H 
model of prostate carcinogenesis (5).  This difference may be due to the aggressive nature of the 
TRAMP model.  Optimal patterns of phytochemicals for reducing prostate carcinogenesis remain 
to be characterized. 
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Table 3.1.  AIN-93G based diet formulations. 
 
 g/100g total diet 
 Control Broccoli 
(Control) 
Broccoli 
(MeJa) 
Cornstarch 39.7 36.6 36.6 
Casein 20.0 16.8 16.8 
Maltodextrin 13.2 13.2 13.2 
Sucrose 10.0 10.0 10.0 
Fiber* 5.0 1.6 1.6 
Mineral mix** 3.5 3.5 3.5 
Vitamin mix*** 1.0 1.0 1.0 
L-Cystine 0.3 0.3 0.3 
Choline bitartrate 0.3 0.3 0.3 
Soybean oil 7.0 6.7 6.7 
Control Broccoli powder  10.0  
MeJa Broccoli powder   10.0 
 
*Non-nutritive cellulose 
**AIN93M-MX formulation 
***AIN93-VX formulation 
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Table 3.2. Grading scheme for adjusted lesion score. 
 
Pathology Grade Distribution Adjusted 
Score 
Normal 0 Diffuse 0 
1 Focal 1 
1 Multifocal 2 
Low grade PIN 
1 Diffuse 3 
2 Focal 4 
2 Multifocal 5 
Moderate grade PIN 
2 Diffuse 6 
3 Focal 7 
3 Multifocal 8 
High grade PIN 
3 Diffuse 9 
4 Focal 10 
4 Multifocal 11 
Phylloides-like tumor 
4 Diffuse 12 
5 Focal 13 
5 Multifocal 14 
Well differentiated carcinoma 
5 Diffuse 15 
6 Focal 16 
6 Multifocal 17 
Moderately differentiated carcinoma 
6 Diffuse 18 
7 Focal 19 
7 Multifocal 20 
Poorly differentiated carcinoma 
7 Diffuse 21 
 
Total adjusted lesion score = score of most severe lesion + score of most common lesion
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Table 3.3.  Glucosinolate profile of broccoli powders. 
 
 µmol/g dry weight 
 Standard 
Broccoli  
MeJa 
Broccoli 
Glucoraphanin 2.49 ± 0.59 3.64 ± 0.59 
Glucobrassicin 2.61 ± 0.07 3.06 ± 0.07* 
Neoglucobrassicin 5.23 ± 0.67 39.77 ± 0.67* 
Gluconastrurtiin 0.87 ± 0.19 3.79 ± 0.19* 
Glucoiberin 0.32 ± 0.08 0.49 ± 0.08 
Progoitrin 0.46 ± 0.07 0.49 ± 0.07 
Sinigrin 0.24 ± 0.02 0.22 ± 0.02 
Gluconapin 0.50 ± 0.03 0.41 ± 0.03 
 
Values are means ± SEM, n=3.   
* within rows indicate significant differences between treatments (P < 0.05). 
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Table 3.4.  Final body weight, food intake, and weight gain. 
 
Treatment Group Final Body 
Weight 
Food Intake Weight Gain 
Control 34.7 ± 0.7 5.1 ± 0.1 14.6 ± 0.7 
Standard Broccoli 35.4 ± 0.8 4.8 ± 0.1 15.6 ± 0.7 
MeJa Broccoli 34.8 ± 0.7 4.9 ± 0.1 14.7 ± 0.7 
 
Values are means ± SEM, n=32-33.  
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Table 3.5.  Adjusted lesion scores of prostate lobes. 
 
Treatment Group Ventral Lateral Dorsal Anterior 
Control 11.5 ± 1.6 25.9 ± 1.1 18.1 ± 0.2 9.0 ± 0.5 
Standard Broccoli 15.4 ± 2.4 29.5 ± 1.3 22.2 ± 1.6 10.4 ± 1.2 
MeJa Broccoli 12.5 ± 2.1 26.2 ± 1.5 20.7 ± 1.5 8.8 ± 0.6 
 
Values are means ± SEM, n=31-33.  Scale ranges from 0 (normal prostate tissue) to 42 (diffuse 
poorly differentiated carcinoma). 
69 
Table 3.6.  Summary of studies with broccoli or broccoli compounds in the TRAMP model. 
 
Study Compound Delivery Route Diet Age at sacrifice Background strain Outcome 
Liu 
(current study) 
Broccoli 10% powder in diet AIN-93G 20 wks C57BL/6 No effect 
Singh 2009 
(18) 
Sulforaphane 6 µmol gavage every 
other day 
Chow 24 wks C57BL/6 X FVB Decreased PIN, WD 
carcinoma, and pulmonary 
metastases  
 
Keum 2009 
(17) 
Broccoli sprout 8% powder in diet AIN-76A 24 wks C57BL/6 Decreased GU tract weight 
Ho 
(unpublished) 
Broccoli sprout 15% powder in diet --- 12 and 28 wks C57BL/6 Decreased WD carcinoma 
and increased PIN at 28 
wks 
 
Cho 2010 
(19) 
3,3’-diindolylmethane 1.5 or 3.0 µmol gavage 
every other day 
Chow 22 wks C57BL/6 Decreased WD carcinoma, 
increased PIN at the 3.0 
µmol dose level 
 
Powolny 2010 
(21) 
Phenethyl isothiocyanate  3 µmol/g in diet AIN-76A 24 wks C57BL/6 X FVB Decreased PD carcinoma 
 
GU: genitourinary tract 
PIN: prostatic intraepithelial neoplasia 
WD: well differentiated carcinoma 
PD: poorly differentiated carcinoma
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Table 3.7.  Dose comparison with other studies. 
 
 Estimated daily intake (µmol/day/mouse), based on average food intake of 5.1 g/day 
Glucosinolate Standard Broccoli MeJa Broccoli 
 
Other Studies 
Glucoraphanin 1.2 1.8 6 µmol gavage of SF every other day (Singh 2009.) 
Estimate 11.3 µmol SF/day from broccoli sprout diet (personal 
communication, E. Ho) 
 
Glucobrassicin 1.3 1.5 3 µmol gavage of DIM every other day (Cho 2009) 
 
Neoglucobrassicin 2.6 19.9  
 
Gluconasturtiin 0.4 1.9 15 µmol PEITC/day (Powolny 2010) 
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Figure 3.1.  A: Liver ethoxyresorufin O-deethylase (EROD) activity, B: Liver NAD(P)H-
quinone oxidoreductase 1 (NQO1) activitty.  Results shown are means ± SEM, n=8.  Samples 
were run in triplicate.  For each enzyme, different letters above bars indicate significant 
differences between treatments (P < 0.05).  
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Figure 3.2.  Genitourinary tract weight.  Dashed lines indicate mean values, n=32-33. 
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Figure 3.3.  Proliferation (A) and apoptosis (B) rates of TRAMP prostates.  Results are shown as 
means ± SEM, n=14. 
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CHAPTER 4 
 
LYCOPENE AND APO-10’-LYCOPENAL DO NOT ALTER DNA METHYLATION OF 
GSTP1 IN LNCAP CELLS 
 
ABSTRACT 
DNA hypermethylation and silencing of tumor-suppressor genes are commonly seen in human 
cancers, and likely contribute to the process of carcinogenesis.  A growing body of evidence 
suggests that dietary compounds may alter cancer risk through epigenetic modifications.  
Glutathione S-transferase P1 (GSTP1) is hypermethylated in >90% of prostate cancer cases 
making it one of the most common genome alterations in prostate cancer.  LNCaP cells were 
treated either with lycopene or apo-10’-lycopenal for 7 days, and mRNA expression and DNA 
methylation of GSTP1 were evaluated.  Neither compound significantly altered expression or 
methylation of GSTP1 while treatment with 5-azacytidine decreased methylation by 78%.  These 
findings demonstrate that lycopene and apo-10’-lycopenal are not effective demethylating agents 
of GSTP1 in the human LNCaP cell line. 
 
INTRODUCTION 
Prostate cancer is the most commonly diagnosed male cancer and second leading cause 
of male cancer deaths in United States with approximately 186,000 new cases diagnosed each 
year (1).  Environmental exposures can alter gene expression through epigenetic modifications 
and these modifications may in turn alter disease susceptibility (2). The two major types of 
epigenetic changes are modifications to DNA, in the form of DNA methylation, and 
modifications to chromatin packaging, specifically histone modification. 
DNA methylation is critical for regulation of gene transcription and structure of the cell 
nucleus.  Aberrant DNA methylation patterns are commonly seen in human cancers which often 
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consist of global hypomethylation of DNA accompanied by hypermethylation of specific tumor-
suppressor genes (3).  Currently, the methylation status of glutathione S-transferase P1 (GSTP1) 
is being investigated to determine if it can serve as an early and specific biomarker of prostate 
cancer (4, 5). 
Gluathione S-transferases (GSTs) are a large family of detoxification enzymes which 
catalyze conjugation reactions with reduced glutathione.  They play an important role in 
protecting DNA from reactive electrophilic compounds and oxidants.  GSTP1 is 
hypermethylated in >90% of prostate cancer cases and 70% of prostatic intraepithelial neoplasia 
(PIN) lesions making it one of the earliest and most commonly found genomic alterations in 
prostate cancer (5).  Mice that are null for GSTP1 develop skin tumors at significantly increased 
rates compared to wild type mice when exposed to the carcinogen 7,12 
dimethylbenz[a]anthracene (6).  GSTP1 is completely silenced in LNCaP human prostate cancer 
cells due to hypermethylation (7).  When these cells are exposed to the carcinogenic heterocyclic 
amine 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), high levels of PhIP-DNA 
adducts are formed, but when the cells are modified to express GSTP1 they are resistant to the 
formation of PhIP-DNA adducts (8).  These data demonstrate that GSTP1 may play a key role in 
the prevention of cancer formation. 
Recent data suggest that dietary compounds may prevent cancer through epigenetic 
modifications in the cell (9, 10). Tomatoes are the second most commonly consumed vegetable 
in the American diet second only to potatoes (11).  In 2007, the average American consumed 
19.2 pounds of fresh tomatoes and 68.8 pounds of processed tomato products (12).  
Epidemiological studies have linked higher consumption of tomatoes and tomato products with 
decreased risk of prostate cancer (13).  In the Health Professionals Follow-Up Study, men who 
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consumed >2 servings of tomato sauce per week had a 23% reduction in risk of prostate cancer 
vs men who consumed <1 serving per month (RR = 0.77; 95% CI = 0.66 to 0.90; Ptrend <.001) 
(14).  The anti-carcinogenic effects of tomatoes are often associated with lycopene, the major 
carotenoid found in tomatoes.  Lycopene has been shown to be a potent antioxidant and exert 
several other anti-carcinogenic effects in vitro including induction of cell cycle arrest (15).  
However, the ability of lycopene to act through epigenetic alterations has thus far only been 
examined in one study where lycopene was shown to partially demethylate the GSTP1 promoter 
and restore GSTP1 expression in breast cancer cell lines (16).  Thus lycopene may also be able to 
prevent or slow prostate cancer growth through alterations in DNA methylation patterns.  Here 
we investigate whether lycopene or one of its reported metabolites, apo-10’-lycopenal, can 
restore expression of GSTP1 in prostate cancer cell lines through demethylation of the GSTP1 
promoter. 
 
 
MATERIALS AND METHODS 
Cell lines and Culture Conditions.  The LNCaP cell line was originally isolated in 1977 
by J.S. Horoszewicz, et al., from a needle aspiration biopsy of the lymph node of a 50-year-old 
Caucasian male with a confirmed diagnosis of metastatic prostate carcinoma (17).  The cells are 
androgen receptor positive and responsive to dihydrotestosterone.  LNCaP cells were purchased 
from American Type Culture Collection (Manassas, VA) and were maintained in RPMI 1640 
media (Sigma-Aldrich, St, Louis, MO) containing 10% fetal bovine serum, 2 mM L-glutamine, 
10 mM HEPES, 1 mM sodium pyruvate, 4.5 g/L glucose, 1.5 g/L sodium bicarbonate, and 5.6 
mg/ml amphotericin B.  Cells were maintained at 37°C with 5% CO2 and atmospheric oxygen 
partial pressure.   
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Carotenoid Preparation.  Doses of lycopene and apo-10’-lycopenal were prepared fresh 
daily.  For lycopene, water-soluble lycopene beadlets (5.7% pure lycopene, DSM Nutritional 
Products, Basel, Switzerland) were dissolved in deionized water and added to 10 mL of media.  
Apo-10’-lycopenal was dissolved in DMSO and added to 5 mL of media.  The resulting stock 
solutions were sonicated and filtered through a 0.22 μm sterile filter.  Solubilization was 
confirmed through quick observation under a light microscope.  Stock lycopene or apo-10’-
lycopenal concentrations were determined by extracting 100 μL of media and measuring 
absorbance via a spectrophotometer (lycopene λmax = 472 nm, A1 cm 
1%
 = 3450 in hexane; apo-
10’-lycopenal λmax = 460 nm, A1 cm 
1%
 = 2684 in hexane).  All carotenoid extracts were kept on 
ice and under yellow lights throughout the extraction process. 
Experimental Design.  In the first experiment, cells were dosed daily with lycopene at 1, 
2, or 4 μM for seven days.  Placebo beadlets were used as a vehicle control.  In the second 
experiment, cells were dosed daily with apo-10’-lycopenal at 0.01, 0.1, or 1 μM for seven days, 
and 0.1 % DMSO was used as a vehicle control.  In both experiments, media were changed daily 
to minimize carotenoid degradation.  Three independent replicates were performed for each 
assay, with n=3 per dose level. 
 5-azacytidine (Sigma-Aldrich, St. Louis, MO) is a known demethylating agent and was 
used as a positive control.  Cells were dosed with 5 μM 5-azacytidine every other day (18).  All 
experiments were carried out under dim light. 
Carotenoid Analysis.  Cells were rinsed with PBS and pelleted.  For cell extraction, cells 
were resuspended in 100 μL of water, and 500 μL of acetone was added.  Samples were 
sonicated for 10 min, centrifuged at 7000 x g for 5 min, and the supernatant was transferred to 
new tube.  The acetone extract was dried down with argon and stored at -20C for 24 h prior to 
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HPLC-PDA analysis.  For medium extraction, 1.0 mL ethanol containing 0.1% butylated 
hydroxytoluene was added to 1.0 mL medium and vortexed.  Media samples were extracted 3 
times with 2.0 mL hexane. Hexane extracts were dried in a Speedvac evaporator (model AS160; 
Savant, Farmingdale, NY), flushed with argon, and stored at -20C for 24 h prior to HPLC-
PDA analysis.  All carotenoid extracts were kept on ice and under yellow lights throughout the 
extraction process. 
Lycopene concentrations were analyzed by a reverse-phase HPLC-PDA system 
previously described (19).  Apo-10’-lycopenal concentrations were analyzed using a similar 
system. The system consisted of two Ranin Dynamax  pumps (Model SD-200; Varian, Walnut 
Creek, CA), a C30 column (4.6 × 250 mm, 3 μm, YMC, Wilmington, NC) with a guard column, 
an 18°C column oven and a photodiode array detector (Model 2996, Waters, Milford, MA) and 
Millenium
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 software (Waters).  Mobile phase A (methanol: 15% ammonium acetate aqueous 
solution= 98:2, v/v) and mobile phase B (methanol: MTBE: 15% ammonium acetate aqueous 
solution= 8:90:2, v/v) were used, and the gradient profile was as follows: 0 min, 0%B; 30 min, 
100%B; 40 min, 100%B; 45 min, 0%B; 50 min, 0%B.  Samples were reconstituted in MTBE for 
injection, and the apo-10’-lycopenal was measured at 460 nm.  All analyses were performed in 
duplicate, and the quantification of carotenoid isomers was carried out by comparing the UV 
spectra and retention times to analytical standards of lycopene or apo-10’-lycopenal (gifts from 
Hansgeorg Ernst, BASF, Ludwigshafen, Germany). 
Real-time quantitative PCR.  Total RNA was extracted from cells using Trizol 
(Invitrogen, Carlsbad, CA) per the manufacturer’s instructions.  cDNA was synthesized using the 
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA).  mRNA 
expression of selected genes was measured via real-time PCR using SYBR Green Master Mix 
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(Applied Biosystems, Foster City, CA).  Reactions were monitored by an ABI Prism 7900HT.  
Primer pairs were designed to measure glutathione-S-transferase  1 (GSTP1) (8) and ribosomal 
protein L7a (RPL7A) (20).  A validation experiment was performed on each set of primers 
(Integrated DNA Technologies, Coralsville, IA) to confirm efficiency and product specificity. A 
serial dilution was used to create a standard curve for quantification. RPL7A was used as a 
housekeeping gene (20). 
Methylation-specific PCR.  Total genomic DNA was extracted from cells using the 
GenElute Mammalian Genomic DNA Miniprep Kit (Sigma-Aldrich, St. Louis, MO).  DNA was 
bisulfite treated using the EZ DNA Methylation-Gold Kit (Zymo Research, Orange, CA).  
MethPrimer (http://www.urogene.com/methprimer) was used to design primer pairs to measure 
methylated GSTP1 forward-5’-GGAAAGAGGGAAAGGTTTTTTC-3’ and reverse-5’-
GCCCTAAAATCCCCGAA-3’and unmethylated GSTP1 forward-5’- 
GGAAAGAGGGAAAGGTTTTTTT -3’ and reverse-5’-AACACCCTAAAATCCCCAAA -3’. 
A serial dilution was used to create a standard curve for quantification.  Reactions were 
monitored by an ABI Prism 7900HT.   
Statistical Analysis.  Dose-response effects were analyzed by linear regression, using the 
REG procedure of SAS Statistical Software (version 9.2; SAS Institute, Cary, NC), and values 
were considered different at P < 0.05.  5-azacytidine treated cells were compared among 
treatments by two-tailed analysis of variance, using the MIXED procedure. Values were 
considered different from controls at P < 0.05 using Tukey’s procedure. 
 
RESULTS AND DISCUSSION 
Cellular Uptake of Carotenoids.  Lycopene was provided at doses considered to be 
physiologically relevant (1 and 2 M) and super-physiological (4 M).  Lycopene was taken up 
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by cells in a dose-dependent manner as shown in Figure 4.1 (P = 0.008).  The average lycopene 
content was 42, 61, and 78 pmol per million cells for 1 M, 2 M, and 4 M dose levels, 
respectively.  These levels are similar to those observed in previous studies with lycopene dosing 
of LNCaP cells (21). 
 When lycopene is enzymatically cleaved by carotenoid monooxygenase II, it yields one 
molecule of apo-10’-lycopenal.  Concentrations of apo-10’-lycopenal are much lower in human 
serum than lycopene.  In human subjects consuming a high tomato juice diet for 8 weeks, the 
average concentration of apo-10’-lycopenal was 0.28 nM (22).  Even though the dose levels used 
in our study are relatively low compared to the concentrations sometimes used by others in cell 
culture experiments, our dose leves would still be considered super-physiological.  The average 
apo-10’-lycopenal content of was 2.5 and 2.3 pmol per million cells for 1 M and 0.1 M dose 
levels, respectively, indicating very poor absorption by LNCaP cells.  At the 0.01 M dose level, 
no apo-10’-lycopenal could be detected in the cells (data not shown).  Thus the cellular 
concentration in LNCaP cells was considerably below what has been reported in human serum.  
There have been no reports of cellular levels of apo-10’-lycopenal, but our lab has previously 
identified apo-8’-lycopenal and apo-12’-lycopenal in the liver of rats following lycopene feeding 
(23). 
GSTP1 Expression and Promoter Methylation.  Expression of GSTP1 and DNA 
methlyation of the GSTP1 promoter were not significantly altered by treatment with either 
lycopene or apo-10’-lycopenal (Figures 4.2 and 4.3).  Treatment with 5-azacytidine resulted in 
significant demethylation and increased expression of GSTP1 as expected (P < 0.05).  These 
results indicate that lycopene in not an effective demethylating agent in LNCaP cells.  It is 
possible that lycopene could have epigenetic effects in different prostate cancer cell lines or on 
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different genes.  It is well known that the degree of hypermethylation of  various genes varies by 
cell line (24).  King-Batoon et al. demonstrated that a single dose of 2 M lycopene partially 
demethylated the GSTP1 promoter in MDA-MB-468 cells but not in MCF-7 cells.  The effect 
was also specific to the GSTP1 as RARβ2, another gene hypermethylated in breast cancer, was 
not affected by lycopene treatment (16). 
 Using lycopene in cell culture can be difficult due to issues with stability and solubility.  
Multiple systems have been used to deliver carotenoids in vitro, and differences could potentially 
arise due to different delivery methods.  Here we used water-soluble lycopene beadlets 
containing approximately 65% all-trans lycopene and 35% cis-isomers, and media was changed 
daily to minimize carotenoid degradation.  However, King-Batoon et al. used tetrahydrofuran as 
a solvent and gave a single lycopene dose at the beginning of the 7-day study.  Lycopene 
solubilized in THF degrades rapidly in cell culture conditions with a half-life of less than 2 hr 
(21).  In contrast, when water-soluble lycopene beadlets are used as a delivery vehicle, 
approximately 80% of the original dose remains in the medium after 24 hours (25).  This 
variation with in vitro techniques can make interpretation of the literature somewhat confusing. 
 In summary, we have shown that lycopene and apo-10’-lycopenal are taken up by LNCaP 
cells but do not alter DNA methylation of GSTP1.  Further research is needed to determine 
whether lycopene might exert epigenetic effects on other tumor suppressor genes in LNCaP cells 
or in other prostate cancer cell lines. 
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Figure 4.1.  Lycopene concentration in LNCaP cells.  Values are means  SEM, n=3.
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Figure 4.2.  GSTP1 mRNA expression (A) and GSTP1 promoter methylation (B) of LNCaP 
cells treated with lycopene. Values are means of three independent experiments  SEM, n=3.  
Asterisk indicates significant differences (P < 0.05). 
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Figure 4.3.  GSTP1 mRNA expression (A) and GSTP1 promoter methylation (B) of LNCaP 
cells treated with apo-10’-lycopenal. Values are means of three independent experiments  SEM, 
n=3.  Asterisk indicates significant differences (P < 0.05). 
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CHAPTER 5 
 
SUMMARY AND FUTURE DIRECTIONS 
 
 Prostate cancer is the most commonly diagnosed male cancer in the United States.  
Dietary intervention could play an important role in delaying prostate cancer growth since it is a 
slow growing cancer that takes decades to develop.  Although individual bioactives have been 
extensively studies for their anti-carcinogenic properties, most people consume these bioactives 
within the diet as part of a whole food.  Recently, some studies have shown that increasing the 
content of specific bioactives with anti-carcinogenic properties in whole tomatoes or broccoli 
enhances their efficacy in reducing the development of various cancers.  Increasing the cancer 
preventive potential of tomatoes and broccoli is especially of interest because over half the U.S. 
population eats less than the recommended 5 or more servings of fruits and vegetables per day.   
 The objective of study 1 (Chapter 2) was to obtain tomato and broccoli powders with 
enhanced levels of specific bioactives and screen them for bioactivity.  We successfully obtained 
tomato powders with significantly increased levels of lycopene alone or total carotenoids as well 
as broccoli powders with increased levels of indole glucosinolates or selenium.  When rats were 
fed diets containing these powders in a short-term feeding study, higher carotenoid content in the 
tomato powders resulted in greater hepatic carotenoid accumulation.  Both indole glucosinolate-
enriched broccoli and selenium-enriched broccoli significantly increased hepatic activity of 
phase I and phase II detoxification enzymes.  These results indicate that the bioactive profile of 
tomatoes and broccoli can be altered through agronomic means, and these alterations can results 
in increased tissue accumulation and enhanced bioactivity in vivo. 
 The objective of study 2 (Chapter 3) was to test the efficacy of standard broccoli and 
MeJa-treated broccoli, which was high in indole glucosinolates, in reducing prostate 
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carcinogenesis in the TRAMP model.  While MeJa treatment increased the level of indole 
glucosinolates 5 times compared to standard broccoli, neither broccoli treatment significantly 
reduced prostate carcinogenesis as measured via genitourinary tract weight and pathologic score.  
Prostatic proliferation and apoptosis were also unchanged by broccoli feeding.  These finding 
were contrary to our hypothesis that broccoli feeding would result in reduced prostate 
carcinogenesis.  It may be that our glucosinolate levels were too low for this aggressive 
transgenic model.  Other studies in the same model, which reported reductions in prostate 
carcinogenesis, have used higher doses or pure compounds or fed broccoli sprouts, which have a 
different phytochemical profile compared to whole broccoli. 
 In study 3 (Chapter 4) we examined whether lycopene or apo-10’-lycopenal could 
epigenetically modify silenced tumor suppressor genes in LNCaP prostate cancer cells.  Neither 
treatment altered DNA methylation of mRNA expression of GSTP1, one of the most commonly 
hypermethylated and silenced genes in prostate cancer.  While this study does not rule out the 
possibility of epigenetic modifications by lycopene, further research is needed to determine 
whether lycopene might alter methylation of other tumor suppressor genes in LNCaP cells or in 
other cell lines. 
 Overall, we have demonstrated that horticultural manipulation of tomatoes or broccoli to 
alter phytochemical profiles is a feasible approach to optimize cancer prevention potential.  
However it remains to be determined what the optimal levels of phytochemicals are for reducing 
carcinogenesis.  While neither broccoli treatment reduced prostate carcinogenesis in the TRAMP 
model, it is possible that either standard or MeJa broccoli could be effective in a less aggressive 
cancer model. 
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In the future it would be useful to utilize different models to examine the effects of 
tomatoes and/or broccoli on different stages of prostate carcinogenesis.  The effect of broccoli on 
cancer initiation would be particularly interesting to look at because certain broccoli bioactives 
are known to induce phase I and phase II detoxification enzymes.  These detoxification systems 
are critical both for activation of pro-carcinogens and for the removal of carcinogens from the 
body.  The balance between competing activating and detoxifying reactions may play a critical 
role in the amount of carcinogen in the body available to react with targets such as DNA.  
Whereas in the work presented here, there was no effect of broccoli on prostate 
carcinogenesis, previous work by our lab in the Dunning model demonstrated that broccoli 
feeding significantly reduced the growth of transplantable tumors indicating that whole broccoli 
powder can exert effects on prostate cancer progression (1).  Thus current evidence is mixed on 
broccoli’s ability to reduce prostate cancer progression possibly due to differences in models.  
Finally, there is some evidence to indicate that broccoli may also be able to slow 
metastatic spread of prostate cancers.  A prospective study of men in the screening arm of the 
Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial found that men with higher 
broccoli intakes had reduced risk for developing stage III or IV tumors, which are cancers that 
have spread outside of the prostate (2).  Additionally, Singh et al. found that dosing TRAMP 
mice with sulforaphane reduced incidence of pulmonary metastases (3).  While this evidence is 
by no means definitive, it does suggest the possibility that broccoli may be able to reduce the 
spread of prostate cancer to other organs.  We plan on determining metastasis incidence in the 
lungs and livers of animals from our study fed control, standard broccoli powder, or MeJa 
broccoli powder in collaboration with our colleagues at the Ohio State University. 
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Much remains to be determined with regards to possible epigenetic effects of tomato and 
broccoli compounds.  Virtually nothing is known about whether tomatoes or individual 
carotenoids exert epigenetic effects.  While one study has reported decreased methylation of 
GSTP1 in breast cancer cells with lycopene treatment, the effect was not consistent over all cell 
lines suggesting that effectiveness can vary widely depending on the type or subtype of cancer as 
well as on the specific gene being examined (4).  It would be useful to define the effects of 
lycopene and other tomato constituents on several genes in several prostate cancer cell lines, or 
to perform in vivo work to examine this effect.  However, the feasibility of in vivo work may be 
limited by model constraints.  We considered examining GSTP1 methylation in our TRAMP 
study, but found that TRAMP mice do not develop GSTP1 hypermethylation as humans do.  
Thus, not all models may be appropriate for studying the hypermethylation of tumor suppressor 
genes in cancer. 
While lycopene may alter DNA methylation in some cancers, sulforaphane has been 
shown to act through alterations in histone acetylation.  Work by Myzak et al. clearly 
demonstrated that sulforaphane was inhibitor of histone deacteylase (HDAC), an enzyme which 
removes acetyl groups from chromatin leading to chromatin condensation and transcriptional 
repression (5).  By inhibiting HDAC, sulforaphane relieves this transcriptional repression so that 
genes can be transcribed normally.  Most of the work thus far has been done with pure 
sulforaphane, and it would be interesting to examine whether this inhibition of HDAC is seen 
with whole broccoli as well. 
In the end, humans consume whole foods so it is important that research should reflect 
the foods that people actually consume at levels that are achievable through dietary consumption.  
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Much remains to be learned about how whole foods can impact the development of prostate 
cancer over a lifetime and possible mechanisms by which they may exert their effects. 
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